Aspirin (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Aspirin" in Turkish language version.

refsWebsite

Global rank Turkish rank

164nih.gov

4^th place

11^th place

156doi.org

2^nd place

4^th place

61web.archive.org

1^st place

35archive.org

6^th place

7worldcat.org

5^th place

8^th place

6books.google.com

3^rd place

5^th place

6harvard.edu

18^th place

47^th place

5handle.net

102^nd place

447^th place

5fda.gov

447^th place

858^th place

4medscape.com

719^th place

582^nd place

3drugs.com

399^th place

156^th place

3cdc.gov

218^th place

269^th place

2medicinescomplete.com

low place

2clincalc.com

3,912^th place

2,106^th place

2sciencehistory.org

3,963^rd place

low place

2uspreventiveservicestaskforce.org

low place

1tga.gov.au

3,984^th place

3,256^th place

1legislation.gov.au

6,658^th place

low place

1canada.ca

1,712^th place

4,961^st place

1acs.org

1,248^th place

1,788^th place

1uwaterloo.ca

3,153^rd place

2,528^th place

1anl.gov

6,358^th place

3,482^nd place

1tut.ac.jp

low place

1iucr.org

low place

1nobelprize.org

301^st place

182^nd place

1americanheart.org

low place

1genericides.org

low place

1cbc.ca

115^th place

433^rd place

1sigmaaldrich.com

924^th place

3,592^nd place

1pharmacopoeia.co.uk

low place

1healthychildren.org

low place

1guideline.gov

low place

1mtak.hu

low place

1npr.org

92^nd place

369^th place

1racgp.org.au

low place

1duke.edu

1,880^th place

4,428^th place

1personalmd.com

low place

1jpp.krakow.pl

low place

1mercksource.com

8,363^rd place

4,739^th place

1mayoclinic.org

1,610^th place

1,902^nd place

1frostburg.edu

low place

7,651^st place

1nhs.uk

1,989^th place

1,187^th place

1clevelandclinic.org

4,925^th place

2,842^nd place

1unt.edu

1,336^th place

5,615^th place

1theguardian.com

12^th place

44^th place

1usda.gov

438^th place

947^th place

1merckvetmanual.com

9,011^th place

8,076^th place

1merckmanuals.com

3,097^th place

3,478^th place

1cornell.edu

332^nd place

550^th place

acs.org

pubsapp.acs.org

"Aspirin". Chemical & Engineering News. 83 (25). 20 Haziran 2005. 21 Nisan 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.

americanheart.org

"Aspirin in heart attack and stroke prevention". American Heart Association. 31 Mart 2008 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Mayıs 2008.

anl.gov

newton.dep.anl.gov

Barrans R (18 Mayıs 2008). "Aspirin aging". Newton BBS. 18 Mayıs 2008 tarihinde kaynağından arşivlendi.

archive.org

Mann CC, Plummer ML (1991). The aspirin wars: money, medicine, and 100 years of rampant competition. 1st. New York: Knopf. s. 27. ISBN 978-0-394-57894-1.
Reynolds EF, (Ed.) (1982). "Aspirin and similar analgesic and anti-inflammatory agents". Martindale: the extra pharmacopoeia. 28th. Rittenhouse Book Distributors. ss. 234-82. ISBN 978-0-85369-160-0.
Palleros DR (2000). Experimental organic chemistry. New York: John Wiley & Sons. s. 494. ISBN 978-0-471-28250-1.
Carstensen JT, Attarchi F (April 1988). "Decomposition of aspirin in the solid state in the presence of limited amounts of moisture III: Effect of temperature and a possible mechanism". Journal of Pharmaceutical Sciences. 77 (4). ss. 318-21. doi:10.1002/jps.2600770407. PMID 3379589.
Hawley SA, Fullerton MD, Ross FA, Schertzer JD, Chevtzoff C, Walker KJ, ve diğerleri. (May 2012). "The ancient drug salicylate directly activates AMP-activated protein kinase". Science. 336 (6083). ss. 918-22. Bibcode:2012Sci...336..918H. doi:10.1126/science.1215327. PMC 3399766 $2. PMID 22517326.
"Clues to aspirin's anti-cancer effects revealed". New Scientist. 214 (2862). 28 Nisan 2012. s. 16. doi:10.1016/S0262-4079(12)61073-2.
Ferguson RK, Boutros AR (August 1970). "Death following self-poisoning with aspirin". JAMA. 213 (7). ss. 1186-8. doi:10.1001/jama.213.7.1186. PMID 5468267.
Kaufman FL, Dubansky AS (April 1972). "Darvon poisoning with delayed salicylism: a case report". Pediatrics. 49 (4). ss. 610-1. doi:10.1542/peds.49.4.610. PMID 5013423.
Levy G, Tsuchiya T (August 1972). "Salicylate accumulation kinetics in man". The New England Journal of Medicine. 287 (9). ss. 430-2. doi:10.1056/NEJM197208312870903. PMID 5044917.
Grootveld M, Halliwell B (January 1988). "2,3-Dihydroxybenzoic acid is a product of human aspirin metabolism". Biochemical Pharmacology. 37 (2). ss. 271-80. doi:10.1016/0006-2952(88)90729-0. PMID 3342084.
Done AK (November 1960). "Salicylate intoxication. Significance of measurements of salicylate in blood in cases of acute ingestion". Pediatrics. Cilt 26. ss. 800-7. doi:10.1542/peds.26.5.800. PMID 13723722.
Schiebinger L (October 2003). "Women's health and clinical trials". The Journal of Clinical Investigation. 112 (7). ss. 973-7. doi:10.1172/JCI19993. PMC 198535 $2. PMID 14523031.
Sachs CJ (March 2005). "Oral analgesics for acute nonspecific pain". American Family Physician. 71 (5). ss. 913-8. PMID 15768621.
Kingery WS (November 1997). "A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes". Pain. 73 (2). ss. 123-139. doi:10.1016/S0304-3959(97)00049-3. PMID 9415498.
Gilmore B, Michael M (February 2011). "Treatment of acute migraine headache". American Family Physician. 83 (3). ss. 271-80. PMID 21302868.
Beutler AI, Chesnut GT, Mattingly JC, Jamieson B (December 2009). "FPIN's Clinical Inquiries. Aspirin use in children for fever or viral syndromes". American Family Physician. 80 (12). s. 1472. PMID 20000310.
Ben-Dor I, Kleiman NS, Lev E (July 2009). "Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy". The American Journal of Cardiology. 104 (2). ss. 227-33. doi:10.1016/j.amjcard.2009.03.022. PMID 19576352.
Hashkes PJ, Tauber T, Somekh E, Brik R, Barash J, Mukamel M, ve diğerleri. (September 2003). "Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial". The Journal of Pediatrics. 143 (3). ss. 399-401. doi:10.1067/S0022-3476(03)00388-3. PMID 14517527.
Dorsch MP, Lee JS, Lynch DR, Dunn SP, Rodgers JE, Schwartz T, ve diğerleri. (May 2007). "Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction". The Annals of Pharmacotherapy. 41 (5). ss. 737-41. doi:10.1345/aph.1H621. PMID 17456544.
Grosser T, Fries S, Lawson JA, Kapoor SC, Grant GR, FitzGerald GA (January 2013). "Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin". Circulation. 127 (3). ss. 377-85. doi:10.1161/CIRCULATIONAHA.112.117283. PMC 3552520 $2. PMID 23212718.
Sørensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, Olsen JH (September 2000). "Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin". The American Journal of Gastroenterology. 95 (9). ss. 2218-2224. doi:10.1016/s0002-9270(00)01040-6. PMID 11007221.
Cox D, Maree AO, Dooley M, Conroy R, Byrne MF, Fitzgerald DJ (August 2006). "Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers". Stroke. 37 (8). ss. 2153-2158. doi:10.1161/01.STR.0000231683.43347.ec. PMID 16794200.
Wallace JL (October 2008). "Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?". Physiological Reviews. 88 (4). ss. 1547-65. doi:10.1152/physrev.00004.2008. PMID 18923189.
Laine L, Maller ES, Yu C, Quan H, Simon T (August 2004). "Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial". Gastroenterology. 127 (2). ss. 395-402. doi:10.1053/j.gastro.2004.05.001. PMID 15300570.
Davison C, Smith BW, Smith PK (August 1962). "Effects of buffered and unbuffered acetylsalicylic acid upon the gastric acidity of normal human subjects". Journal of Pharmaceutical Sciences. 51 (8). ss. 759-763. doi:10.1002/jps.2600510813. PMID 13883982.
Sánchez-Borges M, Capriles-Hulett A (January 2000). "Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity". Annals of Allergy, Asthma & Immunology. 84 (1). ss. 101-6. doi:10.1016/S1081-1206(10)62748-2. PMID 10674573.
Layton AM, Ibbotson SH, Davies JA, Goodfield MJ (July 1994). "Randomised trial of oral aspirin for chronic venous leg ulcers". Lancet. 344 (8916). ss. 164-5. doi:10.1016/s0140-6736(94)92759-6. PMID 7912767.
Gaudreault P, Temple AR, Lovejoy FH (October 1982). "The relative severity of acute versus chronic salicylate poisoning in children: a clinical comparison". Pediatrics. 70 (4). ss. 566-9. doi:10.1542/peds.70.4.566. PMID 7122154.
Marx J (2006). Rosen's emergency medicine: concepts and clinical practice. Mosby/Elsevier. s. 2242. ISBN 978-0-323-02845-5.
Morra P, Bartle WR, Walker SE, Lee SN, Bowles SK, Reeves RA (September 1996). "Serum concentrations of salicylic acid following topically applied salicylate derivatives". The Annals of Pharmacotherapy. 30 (9). ss. 935-40. doi:10.1177/106002809603000903. PMID 8876850.
Baselt R (2011). Disposition of toxic drugs and chemicals in man. 9th. Seal Beach, California: Biomedical Publications. ss. 20-23. ISBN 978-0-9626523-8-7.
Gladding PA, Webster MW, Farrell HB, Zeng IS, Park R, Ruijne N (April 2008). "The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers". The American Journal of Cardiology. 101 (7). ss. 1060-1063. doi:10.1016/j.amjcard.2007.11.054. PMID 18359332.
Hollifield JW (August 1976). "Failure of aspirin to antagonize the antihypertensive effect of spironolactone in low-renin hypertension". Southern Medical Journal. 69 (8). ss. 1034-6. doi:10.1097/00007611-197608000-00022. PMID 785608.
Katzung BG (1998). Basic and clinical pharmacology. McGraw-Hill. s. 584. ISBN 978-0-8385-0565-6.
Lappin MR, (Ed.) (2001). Feline internal medicine secrets. Philadelphia: Hanley & Belfus. s. 160. ISBN 978-1-56053-461-7.

books.google.com

Jones A (2015). Chemistry: An Introduction for Medical and Health Sciences. John Wiley & Sons. ss. 5-6. ISBN 978-0-470-09290-3.
Ravina E (2011). The Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs. John Wiley & Sons. s. 24. ISBN 978-3-527-32669-3. 12 Ocak 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.
Jeffreys D (2008). Aspirin the remarkable story of a wonder drug. Bloomsbury Publishing USA. ISBN 978-1-59691-816-0. 8 Eylül 2017 tarihinde kaynağından arşivlendi.
Myers RL (2007). The 100 most important chemical compounds: a reference guide. ABC-CLIO. s. 10. ISBN 978-0-313-33758-1. 10 Haziran 2013 tarihinde kaynağından arşivlendi.
Huth EJ, ve diğerleri. (CBE Style Manual Committee) (1994). Scientific style and format: the CBE manual for authors, editors, and publishers. Cambridge University Press. s. 164. Bibcode:1994ssfc.book.....S. ISBN 978-0-521-47154-1. 15 Ekim 2015 tarihinde kaynağından arşivlendi.
Livingstone FB (1985). Frequencies of hemoglobin variants: thalassemia, the glucose-6-phosphate dehydrogenase deficiency, G6PD variants, and ovalocytosis in human populations. Oxford University Press. ISBN 978-0-19-503634-3.

canada.ca

health-products.canada.ca

"Aspirin Product information". Health Canada. 22 Ekim 2009. Erişim tarihi: 20 Ağustos 2023.

cbc.ca

"Aspirin: the versatile drug". CBC News. 28 Mayıs 2009. 6 Kasım 2016 tarihinde kaynağından arşivlendi.

cdc.gov

"Acetylsalicylic acid". NIOSH Pocket Guide to Chemical Hazards. U.S. National Institute for Occupational Safety and Health (NIOSH). 11 Nisan 2016. 11 Mayıs 2017 tarihinde kaynağından arşivlendi.
"Appendix G: 1989 Air contaminants update project – Exposure limits NOT in effect". NIOSH pocket guide to chemical hazards. National Institute for Occupational Safety and Health. 13 Şubat 2015. 18 Haziran 2017 tarihinde kaynağından arşivlendi.
"Dengue and dengue hemorrhagic fever: information for health care practitioners". 17 Mart 2008 tarihinde kaynağından arşivlendi. Erişim tarihi: 28 Nisan 2008.

clevelandclinic.org

health.clevelandclinic.org

"Are You Sensitive to Aspirin? Here are Some Reasons Why". Health Essentials from Cleveland Clinic. 5 Şubat 2015. 25 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2020.

clincalc.com

"The Top 300 of 2020". US Government. 1 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022 – ClinCalc vasıtasıyla.
"Aspirin - Drug Usage Statistics, US 2013-2020". ClinCalc. 20 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022.

cornell.edu

ansci.cornell.edu

"Plants poisonous to livestock". Cornell University Department of Animal Science. 16 Ağustos 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Mart 2016.

doi.org

Warner TD, Mitchell JA (October 2002). "Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?". Proceedings of the National Academy of Sciences of the United States of America. 99 (21). ss. 13371-3. Bibcode:2002PNAS...9913371W. doi:10.1073/pnas.222543099. PMC 129677 $2. PMID 12374850.
Carstensen JT, Attarchi F (April 1988). "Decomposition of aspirin in the solid state in the presence of limited amounts of moisture III: Effect of temperature and a possible mechanism". Journal of Pharmaceutical Sciences. 77 (4). ss. 318-21. doi:10.1002/jps.2600770407. PMID 3379589.
Bučar DK, Lancaster RW, Bernstein J (June 2015). "Disappearing polymorphs revisited". Angewandte Chemie. 54 (24). ss. 6972-6993. doi:10.1002/anie.201410356. PMC 4479028 $2. PMID 26031248.
Vishweshwar P, McMahon JA, Oliveira M, Peterson ML, Zaworotko MJ (December 2005). "The predictably elusive form II of aspirin". Journal of the American Chemical Society. 127 (48). ss. 16802-16803. doi:10.1021/ja056455b. PMID 16316223.
Bond AD, Boese R, Desiraju GR (2007). "On the polymorphism of aspirin: crystalline aspirin as intergrowths of two "polymorphic" domains". Angewandte Chemie. 46 (4). ss. 618-622. doi:10.1002/anie.200603373. PMID 17139692.
Vane JR (June 1971). "Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs". Nature. 231 (25). ss. 232-5. doi:10.1038/newbio231232a0. PMID 5284360.
Vane JR, Botting RM (June 2003). "The mechanism of action of aspirin". Thrombosis Research. 110 (5–6). ss. 255-8. doi:10.1016/s0049-3848(03)00379-7. PMID 14592543.
Tohgi H, Konno S, Tamura K, Kimura B, Kawano K (October 1992). "Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin". Stroke. 23 (10). ss. 1400-3. doi:10.1161/01.STR.23.10.1400. PMID 1412574.
Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, ve diğerleri. (May 2009). "Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials". Lancet. 373 (9678). ss. 1849-60. doi:10.1016/S0140-6736(09)60503-1. PMC 2715005 $2. PMID 19482214.
Martínez-González J, Badimon L (2007). "Mechanisms underlying the cardiovascular effects of COX-inhibition: benefits and risks". Current Pharmaceutical Design. 13 (22). ss. 2215-27. doi:10.2174/138161207781368774. PMID 17691994.
Funk CD, FitzGerald GA (November 2007). "COX-2 inhibitors and cardiovascular risk". Journal of Cardiovascular Pharmacology. 50 (5). ss. 470-9. doi:10.1097/FJC.0b013e318157f72d. PMID 18030055.
Romano M, Cianci E, Simiele F, Recchiuti A (August 2015). "Lipoxins and aspirin-triggered lipoxins in resolution of inflammation". European Journal of Pharmacology. Cilt 760. ss. 49-63. doi:10.1016/j.ejphar.2015.03.083. PMID 25895638.
Serhan CN, Chiang N (August 2013). "Resolution phase lipid mediators of inflammation: agonists of resolution". Current Opinion in Pharmacology. 13 (4). ss. 632-40. doi:10.1016/j.coph.2013.05.012. PMC 3732499 $2. PMID 23747022.
Weylandt KH (August 2016). "Docosapentaenoic acid derived metabolites and mediators - The new world of lipid mediator medicine in a nutshell". European Journal of Pharmacology. Cilt 785. ss. 108-115. doi:10.1016/j.ejphar.2015.11.002. PMID 26546723.
Somasundaram S, Sigthorsson G, Simpson RJ, Watts J, Jacob M, Tavares IA, ve diğerleri. (May 2000). "Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat". Alimentary Pharmacology & Therapeutics. 14 (5). ss. 639-50. doi:10.1046/j.1365-2036.2000.00723.x. PMID 10792129.
Paul-Clark MJ, Van Cao T, Moradi-Bidhendi N, Cooper D, Gilroy DW (July 2004). "15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation". The Journal of Experimental Medicine. 200 (1). ss. 69-78. doi:10.1084/jem.20040566. PMC 2213311 $2. PMID 15238606.
McCarty MF, Block KI (September 2006). "Preadministration of high-dose salicylates, suppressors of NF-kappaB activation, may increase the chemosensitivity of many cancers: an example of proapoptotic signal modulation therapy". Integrative Cancer Therapies. 5 (3). ss. 252-68. doi:10.1177/1534735406291499. PMID 16880431.
Silva Caldas AP, Chaves LO, Linhares Da Silva L, De Castro Morais D, Gonçalves Alfenas RD (29 Aralık 2017). "Mechanisms involved in the cardioprotective effect of avocado consumption: A systematic review". International Journal of Food Properties. 20 (sup2). ss. 1675-1685. doi:10.1080/10942912.2017.1352601. ISSN 1094-2912. ...there was postprandial reduction on the plasma concentration of IL-6 and IkBα preservation, followed by the lower activation of NFκB, considered the main transcription factor capable of inducing inflammatory response by stimulating the expression of proinflammatory cytokines, chemokines, and adhesion molecules.
Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, ve diğerleri. (January 2018). "Inflammatory responses and inflammation-associated diseases in organs". Oncotarget. 9 (6). ss. 7204-7218. doi:10.18632/oncotarget.23208. PMC 5805548 $2. PMID 29467962.
Lawrence T (December 2009). "The nuclear factor NF-kappaB pathway in inflammation". Cold Spring Harbor Perspectives in Biology. 1 (6). ss. a001651. doi:10.1101/cshperspect.a001651. PMC 2882124 $2. PMID 20457564.
Hawley SA, Fullerton MD, Ross FA, Schertzer JD, Chevtzoff C, Walker KJ, ve diğerleri. (May 2012). "The ancient drug salicylate directly activates AMP-activated protein kinase". Science. 336 (6083). ss. 918-22. Bibcode:2012Sci...336..918H. doi:10.1126/science.1215327. PMC 3399766 $2. PMID 22517326.
"Clues to aspirin's anti-cancer effects revealed". New Scientist. 214 (2862). 28 Nisan 2012. s. 16. doi:10.1016/S0262-4079(12)61073-2.
Alfonso LF, Srivenugopal KS, Arumugam TV, Abbruscato TJ, Weidanz JA, Bhat GJ (March 2009). "Aspirin inhibits camptothecin-induced p21CIP1 levels and potentiates apoptosis in human breast cancer cells". International Journal of Oncology. 34 (3). ss. 597-608. doi:10.3892/ijo_00000185. PMID 19212664.
Alfonso LF, Srivenugopal KS, Bhat GJ (2009). "Does aspirin acetylate multiple cellular proteins? (Review)". Molecular Medicine Reports. 2 (4). ss. 533-7. doi:10.3892/mmr_00000132. PMID 21475861.
Alfonso LF, Srivenugopal KS, Bhat GJ (4 Haziran 2009). "Does aspirin acetylate multiple cellular proteins? (Review)". Molecular Medicine Reports. 2 (4). ss. 533-537. doi:10.3892/mmr_00000132. PMID 21475861.
Franchi F, Schneider D, Prats J, Fan W, Rollini F, Been L, ve diğerleri. (2021). "TCT-320 Pharmacokinetic and Pharmacodynamic Profile of PL-ASA, a Novel Phospholipid-Aspirin Complex Liquid Formulation, Compared to Enteric-Coated Aspirin at an 81-mg Dose – Results From a Prospective, Randomized, Crossover Study". Journal of the American College of Cardiology. 78 (19). Elsevier BV. s. B131. doi:10.1016/j.jacc.2021.09.1173. ISSN 0735-1097.
Ferguson RK, Boutros AR (August 1970). "Death following self-poisoning with aspirin". JAMA. 213 (7). ss. 1186-8. doi:10.1001/jama.213.7.1186. PMID 5468267.
Kaufman FL, Dubansky AS (April 1972). "Darvon poisoning with delayed salicylism: a case report". Pediatrics. 49 (4). ss. 610-1. doi:10.1542/peds.49.4.610. PMID 5013423.
Levy G, Tsuchiya T (August 1972). "Salicylate accumulation kinetics in man". The New England Journal of Medicine. 287 (9). ss. 430-2. doi:10.1056/NEJM197208312870903. PMID 5044917.
Grootveld M, Halliwell B (January 1988). "2,3-Dihydroxybenzoic acid is a product of human aspirin metabolism". Biochemical Pharmacology. 37 (2). ss. 271-80. doi:10.1016/0006-2952(88)90729-0. PMID 3342084.
Hartwig-Otto H (November 1983). "Pharmacokinetic considerations of common analgesics and antipyretics". The American Journal of Medicine. 75 (5A). ss. 30-7. doi:10.1016/0002-9343(83)90230-9. PMID 6606362.
Done AK (November 1960). "Salicylate intoxication. Significance of measurements of salicylate in blood in cases of acute ingestion". Pediatrics. Cilt 26. ss. 800-7. doi:10.1542/peds.26.5.800. PMID 13723722.
Chyka PA, Erdman AR, Christianson G, Wax PM, Booze LL, Manoguerra AS, ve diğerleri. (2007). "Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management". Clinical Toxicology. 45 (2). ss. 95-131. doi:10.1080/15563650600907140. PMID 17364628.
Prescott LF, Balali-Mood M, Critchley JA, Johnstone AF, Proudfoot AT (November 1982). "Diuresis or urinary alkalinisation for salicylate poisoning?". British Medical Journal. 285 (6352). ss. 1383-6. doi:10.1136/bmj.285.6352.1383. PMC 1500395 $2. PMID 6291695.
Dargan PI, Wallace CI, Jones AL (May 2002). "An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose". Emergency Medicine Journal. 19 (3). ss. 206-9. doi:10.1136/emj.19.3.206. PMC 1725844 $2. PMID 11971828.
D'Agati V (July 1996). "Does aspirin cause acute or chronic renal failure in experimental animals and in humans?". American Journal of Kidney Diseases. 28 (1 Suppl 1). ss. S24-9. doi:10.1016/s0272-6386(96)90565-x. PMID 8669425.
Schiebinger L (October 2003). "Women's health and clinical trials". The Journal of Clinical Investigation. 112 (7). ss. 973-7. doi:10.1172/JCI19993. PMC 198535 $2. PMID 14523031.
"Regular aspirin intake and acute myocardial infarction". British Medical Journal. 1 (5905). March 1974. ss. 440-3. doi:10.1136/bmj.1.5905.440. PMC 1633212 $2. PMID 4816857.
Elwood PC, Cochrane AL, Burr ML, Sweetnam PM, Williams G, Welsby E, ve diğerleri. (March 1974). "A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction". British Medical Journal. 1 (5905). ss. 436-40. doi:10.1136/bmj.1.5905.436. PMC 1633246 $2. PMID 4593555.
Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Erqou S, Sattar N, ve diğerleri. (February 2012). "Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials". Archives of Internal Medicine. 172 (3). ss. 209-16. doi:10.1001/archinternmed.2011.628. hdl:10044/1/34287. PMID 22231610.
McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, ve diğerleri. (October 2018). "Effect of Aspirin on Disability-free Survival in the Healthy Elderly". The New England Journal of Medicine. 379 (16). ss. 1499-1508. doi:10.1056/NEJMoa1800722. hdl:1885/154654. PMC 6426126 $2. PMID 30221596.
McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, ve diğerleri. (October 2018). "Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly". The New England Journal of Medicine. 379 (16). ss. 1509-1518. doi:10.1056/NEJMoa1805819. PMC 6289056 $2. PMID 30221597.
Algra AM, Rothwell PM (May 2012). "Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials". The Lancet. Oncology. 13 (5). ss. 518-27. doi:10.1016/S1470-2045(12)70112-2. PMID 22440112.
Davidson KW, Barry MJ, Mangione CM, Cabana M, Chelmow D, Coker TR, ve diğerleri. (April 2022). "Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement". JAMA. 327 (16). ss. 1577-1584. doi:10.1001/jama.2022.4983. PMID 35471505.
Gaciong Z (June 2003). "The real dimension of analgesic activity of aspirin". Thrombosis Research. 110 (5–6). ss. 361-4. doi:10.1016/j.thromres.2003.08.009. PMID 14592563.
Derry CJ, Derry S, Moore RA (December 2014). "Caffeine as an analgesic adjuvant for acute pain in adults". The Cochrane Database of Systematic Reviews. 2014 (12). ss. CD009281. doi:10.1002/14651858.CD009281.pub3. PMC 6485702 $2. PMID 25502052.
Hersh EV, Moore PA, Ross GL (May 2000). "Over-the-counter analgesics and antipyretics: a critical assessment". Clinical Therapeutics. 22 (5). ss. 500-48. doi:10.1016/S0149-2918(00)80043-0. PMID 10868553.
Mett A, Tfelt-Hansen P (June 2008). "Acute migraine therapy: recent evidence from randomized comparative trials". Current Opinion in Neurology. 21 (3). ss. 331-7. doi:10.1097/WCO.0b013e3282fee843. PMID 18451718.
Kingery WS (November 1997). "A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes". Pain. 73 (2). ss. 123-139. doi:10.1016/S0304-3959(97)00049-3. PMID 9415498.
Loder E, Rizzoli P (January 2008). "Tension-type headache". BMJ. 336 (7635). ss. 88-92. doi:10.1136/bmj.39412.705868.AD. PMC 2190284 $2. PMID 18187725.
Bartfai T, Conti B (March 2010). "Fever". TheScientificWorldJournal. Cilt 10. ss. 490-503. doi:10.1100/tsw.2010.50. PMC 2850202 $2. PMID 20305990.
Pugliese A, Beltramo T, Torre D (October 2008). "Reye's and Reye's-like syndromes". Cell Biochemistry and Function. 26 (7). ss. 741-6. doi:10.1002/cbf.1465. PMID 18711704.
Morris T, Stables M, Hobbs A, de Souza P, Colville-Nash P, Warner T, ve diğerleri. (August 2009). "Effects of low-dose aspirin on acute inflammatory responses in humans". Journal of Immunology. 183 (3). ss. 2089-96. doi:10.4049/jimmunol.0900477. PMID 19597002.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, ve diğerleri. (September 2019). "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Journal of the American College of Cardiology. 74 (10). ss. e177-e232. doi:10.1016/j.jacc.2019.03.010. PMC 7685565 $2. PMID 30894318.
Rothwell PM, Cook NR, Gaziano JM, Price JF, Belch JF, Roncaglioni MC, ve diğerleri. (August 2018). "Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials". Lancet. 392 (10145). ss. 387-399. doi:10.1016/S0140-6736(18)31133-4. PMC 6083400 $2. PMID 30017552.
Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, Barton J, ve diğerleri. (October 2018). "Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus". The New England Journal of Medicine. 379 (16). ss. 1529-1539. doi:10.1056/NEJMoa1804988. PMID 30146931.
Woods RL, Polekhina G, Wolfe R, Nelson MR, Ernst ME, Reid CM, ve diğerleri. (March 2020). "No Modulation of the Effect of Aspirin by Body Weight in Healthy Older Men and Women". Circulation. 141 (13). ss. 1110-1112. doi:10.1161/CIRCULATIONAHA.119.044142. PMC 7286412 $2. PMID 32223674.
Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK (August 2001). "Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation" (PDF). The New England Journal of Medicine. 345 (7). ss. 494-502. doi:10.1056/nejmoa010746. PMID 11519503. 6 Ocak 2022 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 10 Aralık 2023.
Costa F, Vranckx P, Leonardi S, Moscarella E, Ando G, Calabro P, ve diğerleri. (May 2015). "Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial". European Heart Journal. 36 (20). ss. 1242-51. doi:10.1016/s0735-1097(15)61590-x . PMID 25718355.
Khan SU, Singh M, Valavoor S, Khan MU, Lone AN, Khan MZ, ve diğerleri. (October 2020). "Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis". Circulation. 142 (15). ss. 1425-1436. doi:10.1161/CIRCULATIONAHA.120.046308. PMC 7547897 $2. PMID 32795096.
Capodanno D, Alfonso F, Levine GN, Valgimigli M, Angiolillo DJ (December 2018). "ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison". Journal of the American College of Cardiology. 72 (23 Pt A). ss. 2915-2931. doi:10.1016/j.jacc.2018.09.057. PMID 30522654.
Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, ve diğerleri. (September 2016). "2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Journal of the American College of Cardiology. 68 (10). ss. 1082-115. doi:10.1016/j.jacc.2016.03.513. PMID 27036918.
Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, ve diğerleri. (January 2018). "2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)". European Heart Journal. 39 (3). ss. 213-260. doi:10.1093/eurheartj/ehx419. PMID 28886622.
Visseren FL, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, ve diğerleri. (September 2021). "2021 ESC Guidelines on cardiovascular disease prevention in clinical practice". European Heart Journal. 42 (34). ss. 3227-3337. doi:10.1093/eurheartj/ehab484. PMID 34458905.
Norris JW (September 2005). "Antiplatelet agents in secondary prevention of stroke: a perspective". Stroke. 36 (9). ss. 2034-6. doi:10.1161/01.STR.0000177887.14339.46. PMID 16100022.
Sleight P, Pouleur H, Zannad F (July 2006). "Benefits, challenges, and registerability of the polypill". European Heart Journal. 27 (14). ss. 1651-6. doi:10.1093/eurheartj/ehi841. PMID 16603580.
Wang TH, Bhatt DL, Topol EJ (March 2006). "Aspirin and clopidogrel resistance: an emerging clinical entity". European Heart Journal. 27 (6). ss. 647-54. doi:10.1093/eurheartj/ehi684. PMID 16364973.
Oliveira DC, Silva RF, Silva DJ, Lima VC (September 2010). "Aspirin resistance: fact or fiction?". Arquivos Brasileiros de Cardiologia. 95 (3). ss. e91-4. doi:10.1590/S0066-782X2010001300024. PMID 20944898.
Topçuoglu MA, Arsava EM, Ay H (February 2011). "Antiplatelet resistance in stroke". Expert Review of Neurotherapeutics. 11 (2). ss. 251-63. doi:10.1586/ern.10.203. PMC 3086673 $2. PMID 21306212.
Ben-Dor I, Kleiman NS, Lev E (July 2009). "Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy". The American Journal of Cardiology. 104 (2). ss. 227-33. doi:10.1016/j.amjcard.2009.03.022. PMID 19576352.
Davidson KW, Barry MJ, Mangione CM, Cabana M, Chelmow D, Coker TR, ve diğerleri. (April 2022). "Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement". JAMA. 327 (16). ss. 1577-1584. doi:10.1001/jama.2022.4983. PMID 35471505.
Cuzick J, Thorat MA, Bosetti C, Brown PH, Burn J, Cook NR, ve diğerleri. (January 2015). "Estimates of benefits and harms of prophylactic use of aspirin in the general population". Annals of Oncology. 26 (1). ss. 47-57. doi:10.1093/annonc/mdu225. PMC 4269341 $2. PMID 25096604.
Manzano A, Pérez-Segura P (29 Nisan 2012). "Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?". TheScientificWorldJournal. Cilt 2012. s. 327341. doi:10.1100/2012/327341. PMC 3353298 $2. PMID 22649288.
Chan AT, Arber N, Burn J, Chia WK, Elwood P, Hull MA, ve diğerleri. (February 2012). "Aspirin in the chemoprevention of colorectal neoplasia: an overview". Cancer Prevention Research. 5 (2). ss. 164-78. doi:10.1158/1940-6207.CAPR-11-0391. PMC 3273592 $2. PMID 22084361.
Thun MJ, Jacobs EJ, Patrono C (April 2012). "The role of aspirin in cancer prevention". Nature Reviews. Clinical Oncology. 9 (5). ss. 259-67. doi:10.1038/nrclinonc.2011.199. PMID 22473097.
Richman IB, Owens DK (July 2017). "Aspirin for Primary Prevention". The Medical Clinics of North America. 101 (4). ss. 713-724. doi:10.1016/j.mcna.2017.03.004. PMID 28577622.
Verdoodt F, Friis S, Dehlendorff C, Albieri V, Kjaer SK (February 2016). "Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: A systematic review and meta-analysis of observational studies". Gynecologic Oncology. 140 (2). ss. 352-8. doi:10.1016/j.ygyno.2015.12.009. PMID 26701413.
Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C (June 2012). "Aspirin and cancer risk: a quantitative review to 2011". Annals of Oncology. 23 (6). ss. 1403-15. doi:10.1093/annonc/mds113. PMID 22517822.
Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Kandala NB, ve diğerleri. (September 2013). "Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews". Health Technology Assessment. 17 (43). ss. 1-253. doi:10.3310/hta17430. PMC 4781046 $2. PMID 24074752.
U.S. Preventive Services Task Force (March 2007). "Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement". Annals of Internal Medicine. 146 (5). ss. 361-4. doi:10.7326/0003-4819-146-5-200703060-00008. PMID 17339621.
Bibbins-Domingo K (June 2016). "Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement". Annals of Internal Medicine. 164 (12). ss. 836-45. doi:10.7326/m16-0577. PMID 27064677.
Bosetti C, Santucci C, Gallus S, Martinetti M, La Vecchia C (May 2020). "Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019". Annals of Oncology. 31 (5). ss. 558-568. doi:10.1016/j.annonc.2020.02.012. PMID 32272209. The present comprehensive meta-analysis supports and further quantifies the inverse association between regular aspirin use and the risk of colorectal and other digestive tract cancers, including some rare ones. The favorable effect of aspirin increases with longer duration of use, and, for colorectal cancer, with increasing dose.
McNeil JJ, Nelson MR, Woods RL, Lockery JE, Wolfe R, Reid CM, ve diğerleri. (October 2018). "Effect of Aspirin on All-Cause Mortality in the Healthy Elderly". The New England Journal of Medicine. 379 (16). ss. 1519-1528. doi:10.1056/NEJMoa1803955. PMC 6433466 $2. PMID 30221595.
Bartoli F, Cavaleri D, Bachi B, Moretti F, Riboldi I, Crocamo C, Carrà G (November 2021). "Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials". Journal of Psychiatric Research. Cilt 143. ss. 230-238. doi:10.1016/j.jpsychires.2021.09.018. PMID 34509090.
Dominiak M, Gędek A, Sikorska M, Mierzejewski P, Wojnar M, Antosik-Wójcińska AZ (December 2022). "Acetylsalicylic Acid and Mood Disorders: A Systematic Review". Pharmaceuticals. 16 (1). s. 67. doi:10.3390/ph16010067. PMC 9861965 $2. PMID 36678565.
Savitz JB, Teague TK, Misaki M, Macaluso M, Wurfel BE, Meyer M, ve diğerleri. (January 2018). "Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial". Translational Psychiatry. 8 (1). s. 27. doi:10.1038/s41398-017-0073-7. PMC 5802452 $2. PMID 29362444.
Bauer IE, Green C, Colpo GD, Teixeira AL, Selvaraj S, Durkin K, ve diğerleri. (December 2018). "A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression". The Journal of Clinical Psychiatry. 80 (1). doi:10.4088/JCP.18m12200. PMID 30549489.
Li H, Li W, Zhang X, Ma XC, Zhang RW (4 Şubat 2021). "Aspirin Use on Incident Dementia and Mild Cognitive Decline: A Systematic Review and Meta-Analysis". Frontiers in Aging Neuroscience. Cilt 12. s. 578071. doi:10.3389/fnagi.2020.578071. PMC 7890199 $2. PMID 33613260.
Veronese N, Stubbs B, Maggi S, Thompson T, Schofield P, Muller C, ve diğerleri. (August 2017). "Low-Dose Aspirin Use and Cognitive Function in Older Age: A Systematic Review and Meta-analysis". Journal of the American Geriatrics Society. 65 (8). ss. 1763-1768. doi:10.1111/jgs.14883. PMC 6810633 $2. PMID 28425093.
Schmidt L, Phelps E, Friedel J, Shokraneh F (August 2019). "Acetylsalicylic acid (aspirin) for schizophrenia". The Cochrane Database of Systematic Reviews. 2019 (8). ss. CD012116. doi:10.1002/14651858.CD012116.pub2. PMC 6699651 $2. PMID 31425623.
Fond G, Lançon C, Korchia T, Auquier P, Boyer L (2020). "The Role of Inflammation in the Treatment of Schizophrenia". Frontiers in Psychiatry. Cilt 11. s. 160. doi:10.3389/fpsyt.2020.00160. PMC 7093323 $2. PMID 32256401.
Hashkes PJ, Tauber T, Somekh E, Brik R, Barash J, Mukamel M, ve diğerleri. (September 2003). "Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial". The Journal of Pediatrics. 143 (3). ss. 399-401. doi:10.1067/S0022-3476(03)00388-3. PMID 14517527.
Rowley AH, Shulman ST (February 2010). "Pathogenesis and management of Kawasaki disease". Expert Review of Anti-Infective Therapy. 8 (2). ss. 197-203. doi:10.1586/eri.09.109. PMC 2845298 $2. PMID 20109049.
Baumer JH, Love SJ, Gupta A, Haines LC, Maconochie I, Dua JS (October 2006). "Salicylate for the treatment of Kawasaki disease in children". The Cochrane Database of Systematic Reviews. 2010 (4). ss. CD004175. doi:10.1002/14651858.CD004175.pub2. PMC 8765111 $2. PMID 17054199.
Duley L, Meher S, Hunter KE, Seidler AL, Askie LM (October 2019). "Antiplatelet agents for preventing pre-eclampsia and its complications". The Cochrane Database of Systematic Reviews. 2019 (10). doi:10.1002/14651858.CD004659.pub3. PMC 6820858 $2. PMID 31684684.
Roberge S, Villa P, Nicolaides K, Giguère Y, Vainio M, Bakthi A, ve diğerleri. (2012). "Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis". Fetal Diagnosis and Therapy. 31 (3). ss. 141-6. doi:10.1159/000336662. PMID 22441437.
Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E (February 2017). "The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis". American Journal of Obstetrics and Gynecology. 216 (2). ss. 110-120.e6. doi:10.1016/j.ajog.2016.09.076. PMID 27640943.
Szabó B, Németh K, Mészáros K, Krokker L, Likó I, Saskői E, ve diğerleri. (5 Eylül 2022). "Aspirin Mediates Its Antitumoral Effect Through Inhibiting PTTG1 in Pituitary Adenoma". The Journal of Clinical Endocrinology and Metabolism. 107 (11). ss. 3066-3079. doi:10.1210/clinem/dgac496. PMC 9681612 $2. PMID 36059148.
Dorsch MP, Lee JS, Lynch DR, Dunn SP, Rodgers JE, Schwartz T, ve diğerleri. (May 2007). "Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction". The Annals of Pharmacotherapy. 41 (5). ss. 737-41. doi:10.1345/aph.1H621. PMID 17456544.
Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR (January 2008). "Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis". BMJ. 336 (7637). ss. 195-8. doi:10.1136/bmj.39430.529549.BE. PMC 2213873 $2. PMID 18202034.
Pignatelli P, Di Santo S, Barillà F, Gaudio C, Violi F (October 2008). "Multiple anti-atherosclerotic treatments impair aspirin compliance: effects on aspirin resistance". Journal of Thrombosis and Haemostasis. 6 (10). ss. 1832-4. doi:10.1111/j.1538-7836.2008.03122.x. PMID 18680540.
Grosser T, Fries S, Lawson JA, Kapoor SC, Grant GR, FitzGerald GA (January 2013). "Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin". Circulation. 127 (3). ss. 377-85. doi:10.1161/CIRCULATIONAHA.112.117283. PMC 3552520 $2. PMID 23212718.
Li J, Song M, Jian Z, Guo W, Chen G, Jiang G, ve diğerleri. (2014). "Laboratory aspirin resistance and the risk of major adverse cardiovascular events in patients with coronary heart disease on confirmed aspirin adherence". Journal of Atherosclerosis and Thrombosis. 21 (3). ss. 239-47. doi:10.5551/jat.19521. PMID 24201035.
Sofi F, Marcucci R, Gori AM, Abbate R, Gensini GF (August 2008). "Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events--a meta-analysis". International Journal of Cardiology. 128 (2). ss. 166-71. doi:10.1016/j.ijcard.2007.12.010. hdl:2158/323452. PMID 18242733.
Shim EJ, Ryu CW, Park S, Lee HN, Shin HS, Kim SB (October 2018). "Relationship between adverse events and antiplatelet drug resistance in neurovascular intervention: a meta-analysis". Journal of NeuroInterventional Surgery. 10 (10). ss. 942-948. doi:10.1136/neurintsurg-2017-013632. PMID 29352056.
Fiolaki A, Katsanos AH, Kyritsis AP, Papadaki S, Kosmidou M, Moschonas IC, ve diğerleri. (May 2017). "High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: A systematic review and meta-analysis". Journal of the Neurological Sciences. Cilt 376. ss. 112-116. doi:10.1016/j.jns.2017.03.010. PMID 28431593.
Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Huisman MV (13 Ağustos 2007). "Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis". Archives of Internal Medicine. 167 (15). ss. 1593-9. doi:10.1001/archinte.167.15.1593. PMID 17698681.
van Oosterom N, Barras M, Bird R, Nusem I, Cottrell N (December 2020). "A Narrative Review of Aspirin Resistance in VTE Prophylaxis for Orthopaedic Surgery". Drugs. 80 (18). ss. 1889-1899. doi:10.1007/s40265-020-01413-w. PMID 33037568.
US Preventive Services Task Force (March 2009). "Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement". Annals of Internal Medicine. 150 (6). ss. 396-404. doi:10.7326/0003-4819-150-6-200903170-00008. PMID 19293072.
Berger JS, Brown DL, Burke GL, Oberman A, Kostis JB, Langer RD, ve diğerleri. (March 2009). "Aspirin Use, Dose, and Clinical Outcomes in Postmenopausal Women With Stable Cardiovascular Disease". Circulation: Cardiovascular Quality and Outcomes. 2 (2). ss. 78-87. doi:10.1161/circoutcomes.108.791269. ISSN 1941-7713. PMC 2801891 $2. PMID 20031819.
Sacristán JA (August 2021). "Aspirin Dosing in Cardiovascular Disease". New England Journal of Medicine. 385 (8). ss. 764-765. doi:10.1056/nejmc2110476. ISSN 0028-4793. PMID 34407352.
Senna GE, Andri G, Dama AR, Mezzelani P, Andri L (1995). "Tolerability of imidazole salycilate in aspirin-sensitive patients". Allergy Proceedings. 16 (5). ss. 251-254. doi:10.2500/108854195778702675. PMID 8566739.
Zhang Y, Neogi T, Chen C, Chaisson C, Hunter DJ, Choi H (February 2014). "Low-dose aspirin use and recurrent gout attacks". Annals of the Rheumatic Diseases. 73 (2). ss. 385-390. doi:10.1136/annrheumdis-2012-202589. PMC 3902644 $2. PMID 23345599.
Polkinghorne KR, Wetmore JB, Thao LT, Wolfe R, Woods RL, Ernst ME, ve diğerleri. (December 2022). "Effect of Aspirin on CKD Progression in Older Adults: Secondary Analysis From the ASPREE Randomized Clinical Trial". American Journal of Kidney Diseases. 80 (6). ss. 810-813. doi:10.1053/j.ajkd.2022.02.019. PMC 9562592 $2. PMID 35430328.
Mann JF, Joseph P, Gao P, Pais P, Tyrwhitt J, Xavier D, ve diğerleri. (February 2023). "Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease". Kidney International. 103 (2). ss. 403-410. doi:10.1016/j.kint.2022.09.023. PMID 36341885.
Macdonald S (November 2002). "Aspirin use to be banned in under 16 year olds". BMJ. 325 (7371). ss. 988c-988. doi:10.1136/bmj.325.7371.988/c. PMC 1169585 $2. PMID 12411346.
Sørensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, Olsen JH (September 2000). "Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin". The American Journal of Gastroenterology. 95 (9). ss. 2218-2224. doi:10.1016/s0002-9270(00)01040-6. PMID 11007221.
Kedir HM, Sisay EA, Abiye AA (2021). "Enteric-Coated Aspirin and the Risk of Gastrointestinal Side Effects: A Systematic Review". International Journal of General Medicine. Cilt 14. ss. 4757-4763. doi:10.2147/ijgm.s326929. PMC 8403009 $2. PMID 34466020.
Cox D, Maree AO, Dooley M, Conroy R, Byrne MF, Fitzgerald DJ (August 2006). "Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers". Stroke. 37 (8). ss. 2153-2158. doi:10.1161/01.STR.0000231683.43347.ec. PMID 16794200.
Delaney JA, Opatrny L, Brophy JM, Suissa S (August 2007). "Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding". CMAJ. 177 (4). ss. 347-351. doi:10.1503/cmaj.070186. PMC 1942107 $2. PMID 17698822.
Wallace JL (October 2008). "Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?". Physiological Reviews. 88 (4). ss. 1547-65. doi:10.1152/physrev.00004.2008. PMID 18923189.
Laine L, Maller ES, Yu C, Quan H, Simon T (August 2004). "Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial". Gastroenterology. 127 (2). ss. 395-402. doi:10.1053/j.gastro.2004.05.001. PMID 15300570.
Fiorucci S, Santucci L, Wallace JL, Sardina M, Romano M, del Soldato P, ve diğerleri. (September 2003). "Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa". Proceedings of the National Academy of Sciences of the United States of America. 100 (19). ss. 10937-41. Bibcode:2003PNAS..10010937F. doi:10.1073/pnas.1933204100. PMC 196906 $2. PMID 12960371.
Rostom A, Muir K, Dubé C, Jolicoeur E, Boucher M, Joyce J, ve diğerleri. (July 2007). "Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review". Clinical Gastroenterology and Hepatology. 5 (7). ss. 818-28, 828.e1-5; quiz 768. doi:10.1016/j.cgh.2007.03.011. PMID 17556027.
Davison C, Smith BW, Smith PK (August 1962). "Effects of buffered and unbuffered acetylsalicylic acid upon the gastric acidity of normal human subjects". Journal of Pharmaceutical Sciences. 51 (8). ss. 759-763. doi:10.1002/jps.2600510813. PMID 13883982.
Dammann HG, Saleki M, Torz M, Schulz HU, Krupp S, Schürer M, ve diğerleri. (February 2004). "Effects of buffered and plain acetylsalicylic acid formulations with and without ascorbic acid on gastric mucosa in healthy subjects". Alimentary Pharmacology & Therapeutics. 19 (3). ss. 367-74. doi:10.1111/j.1365-2036.2004.01742.x. PMID 14984384.
Hayreh SS (July 2014). "Ocular vascular occlusive disorders: natural history of visual outcome". Progress in Retinal and Eye Research. Cilt 41. ss. 1-25. doi:10.1016/j.preteyeres.2014.04.001. PMC 4073304 $2. PMID 24769221.
Ageno W, Beyer-Westendorf J, Garcia DA, Lazo-Langner A, McBane RD, Paciaroni M (January 2016). "Guidance for the management of venous thrombosis in unusual sites". Journal of Thrombosis and Thrombolysis. 41 (1). ss. 129-43. doi:10.1007/s11239-015-1308-1. PMC 4715841 $2. PMID 26780742.
Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A, Schonberger LB (May 1999). "Reye's syndrome in the United States from 1981 through 1997". The New England Journal of Medicine. 340 (18). ss. 1377-82. doi:10.1056/NEJM199905063401801. PMID 10228187.
Doña I, Barrionuevo E, Salas M, Laguna JJ, Agúndez J, García-Martín E, ve diğerleri. (November 2018). "NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs". Scientific Reports. 8 (1). s. 16710. Bibcode:2018NatSR...816710D. doi:10.1038/s41598-018-34668-1. PMC 6232098 $2. PMID 30420763.
Kowalski ML, Agache I, Bavbek S, Bakirtas A, Blanca M, Bochenek G, ve diğerleri. (January 2019). "Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper". Allergy. 74 (1). ss. 28-39. doi:10.1111/all.13599. PMID 30216468.
Sánchez-Borges M, Capriles-Hulett A (January 2000). "Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity". Annals of Allergy, Asthma & Immunology. 84 (1). ss. 101-6. doi:10.1016/S1081-1206(10)62748-2. PMID 10674573.
Stadelmann WK, Digenis AG, Tobin GR (August 1998). "Impediments to wound healing". American Journal of Surgery. 176 (2A Suppl). ss. 39S-47S. doi:10.1016/S0002-9610(98)00184-6. PMID 9777971.
Layton AM, Ibbotson SH, Davies JA, Goodfield MJ (July 1994). "Randomised trial of oral aspirin for chronic venous leg ulcers". Lancet. 344 (8916). ss. 164-5. doi:10.1016/s0140-6736(94)92759-6. PMID 7912767.
del Río Solá ML, Antonio J, Fajardo G, Vaquero Puerta C (July 2012). "Influence of aspirin therapy in the ulcer associated with chronic venous insufficiency". Annals of Vascular Surgery. 26 (5). ss. 620-9. doi:10.1016/j.avsg.2011.02.051. hdl:10324/2904. PMID 22437068.
de Oliveira Carvalho PE, Magolbo NG, De Aquino RF, Weller CD, ve diğerleri. (Cochrane Wounds Group) (February 2016). "Oral aspirin for treating venous leg ulcers". The Cochrane Database of Systematic Reviews. 2016 (2). ss. CD009432. doi:10.1002/14651858.CD009432.pub2. PMC 8627253 $2. PMID 26889740.
Jull A, Wadham A, Bullen C, Parag V, Kerse N, Waters J (November 2017). "Low dose aspirin as adjuvant treatment for venous leg ulceration: pragmatic, randomised, double blind, placebo controlled trial (Aspirin4VLU)". BMJ. Cilt 359. ss. j5157. doi:10.1136/bmj.j5157. PMC 5701114 $2. PMID 29175902.
Tilbrook H, Clark L, Cook L, Bland M, Buckley H, Chetter I, ve diğerleri. (October 2018). "AVURT: aspirin versus placebo for the treatment of venous leg ulcers - a Phase II pilot randomised controlled trial". Health Technology Assessment. 22 (55). ss. 1-138. doi:10.3310/hta22550. PMC 6204573 $2. PMID 30325305.
Berges-Gimeno MP, Stevenson DD (June 2004). "Nonsteroidal anti-inflammatory drug-induced reactions and desensitization". The Journal of Asthma. 41 (4). ss. 375-84. doi:10.1081/JAS-120037650. PMID 15281324.
Vernooij MW, Haag MD, van der Lugt A, Hofman A, Krestin GP, Stricker BH, ve diğerleri. (June 2009). "Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study". Archives of Neurology. 66 (6). ss. 714-20. doi:10.1001/archneurol.2009.42. PMID 19364926.
Gorelick PB (June 2009). "Cerebral microbleeds: evidence of heightened risk associated with aspirin use". Archives of Neurology. 66 (6). ss. 691-3. doi:10.1001/archneurol.2009.85. PMID 19506128.
He J, Whelton PK, Vu B, Klag MJ (December 1998). "Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials". JAMA. 280 (22). ss. 1930-5. doi:10.1001/jama.280.22.1930. PMID 9851479.
Saloheimo P, Ahonen M, Juvela S, Pyhtinen J, Savolainen ER, Hillbom M (January 2006). "Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death". Stroke. 37 (1). ss. 129-33. doi:10.1161/01.STR.0000196991.03618.31. PMID 16322483.
Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, ve diğerleri. (November 2006). "A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease". European Heart Journal. 27 (22). ss. 2667-2674. doi:10.1093/eurheartj/ehl334. PMID 17053008.
Gaudreault P, Temple AR, Lovejoy FH (October 1982). "The relative severity of acute versus chronic salicylate poisoning in children: a clinical comparison". Pediatrics. 70 (4). ss. 566-9. doi:10.1542/peds.70.4.566. PMID 7122154.
Morra P, Bartle WR, Walker SE, Lee SN, Bowles SK, Reeves RA (September 1996). "Serum concentrations of salicylic acid following topically applied salicylate derivatives". The Annals of Pharmacotherapy. 30 (9). ss. 935-40. doi:10.1177/106002809603000903. PMID 8876850.
Alqahtani Z, Jamali F (2018). "Clinical Outcomes of Aspirin Interaction with Other Non-Steroidal Anti-Inflammatory Drugs: A Systematic Review". Journal of Pharmacy & Pharmaceutical Sciences. 21 (1s). ss. 48s-73s. doi:10.18433/jpps29854. PMID 29891025.
Gladding PA, Webster MW, Farrell HB, Zeng IS, Park R, Ruijne N (April 2008). "The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers". The American Journal of Cardiology. 101 (7). ss. 1060-1063. doi:10.1016/j.amjcard.2007.11.054. PMID 18359332.
Hollifield JW (August 1976). "Failure of aspirin to antagonize the antihypertensive effect of spironolactone in low-renin hypertension". Southern Medical Journal. 69 (8). ss. 1034-6. doi:10.1097/00007611-197608000-00022. PMID 785608.
Loh HS, Watters K, Wilson CW (1 Kasım 1973). "The effects of aspirin on the metabolic availability of ascorbic acid in human beings". Journal of Clinical Pharmacology. 13 (11). ss. 480-486. doi:10.1002/j.1552-4604.1973.tb00203.x. PMID 4490672.
Ioannides C, Stone AN, Breacker PJ, Basu TK (December 1982). "Impairment of absorption of ascorbic acid following ingestion of aspirin in guinea pigs". Biochemical Pharmacology. 31 (24). ss. 4035-4038. doi:10.1016/0006-2952(82)90652-9. PMID 6818974.
"Randomised Trial of Intravenous Streptokinase, Oral Aspirin, Both, or Neither Among 17,187 Cases of Suspected Acute Myocardial Infarction: Isis-2". The Lancet. 332 (8607). August 1988. ss. 349-360. doi:10.1016/s0140-6736(88)92833-4. ISSN 0140-6736. PMID 2899772.
Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, ve diğerleri. (August 1983). "Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study". New England Journal of Medicine. 309 (7). ss. 396-403. doi:10.1056/NEJM198308183090703. ISSN 0028-4793. PMID 6135989.
Di Bella S, Luzzati R, Principe L, Zerbato V, Meroni E, Giuffrè M, ve diğerleri. (25 Ocak 2022). "Aspirin and Infection: A Narrative Review". Biomedicines. 10 (2). s. 263. doi:10.3390/biomedicines10020263. ISSN 2227-9059. PMC 8868581 $2. PMID 35203473.
Cao Y, Tan A (September 2020). "Aspirin might reduce the incidence of breast cancer: An updated meta-analysis of 38 observational studies". Medicine. 99 (38). ss. e21917. doi:10.1097/md.0000000000021917. PMC 7505405 $2. PMID 32957311.
Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, ve diğerleri. (July 2005). "Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial". JAMA. 294 (1). ss. 47-55. doi:10.1001/jama.294.1.47. PMID 15998890.

drugs.com

"Aspirin Use During Pregnancy". Drugs.com. 2 Nisan 2018. 12 Ekim 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Aralık 2019.
"Aspirin". American Society of Health-System Pharmacists. 29 Kasım 2021. 25 Nisan 2017 tarihinde kaynağından arşivlendi – Drugs.com vasıtasıyla.
"Aspirin information from Drugs.com". Drugs.com. 9 Mayıs 2008 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Mayıs 2008.

duke.edu

digitaldukemed.mc.duke.edu

"Invention of the safety cap". digitaldukemed.mc.duke.edu. 4 Mart 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 4 Eylül 2015.

fda.gov

Bu madde bu kaynaktan gelen kamu malı içermektedir: "Aspirin for reducing your risk of heart attack and stroke: know the facts". U.S. Food and Drug Administration (FDA). 14 Ağustos 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Temmuz 2012.
"51 FR 8180" (PDF). United States Federal Register. 51 (45). 7 Mart 1986. 19 Ağustos 2011 tarihinde kaynağından (PDF) arşivlendi.
Bu madde bu kaynaktan gelen kamu malı içermektedir: "FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications". U.S. Food and Drug Administration (FDA) (Basın açıklaması). 15 Ekim 2020. 16 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Ekim 2020.
Bu madde bu kaynaktan gelen kamu malı içermektedir: "NSAIDs may cause rare kidney problems in unborn babies". U.S. Food and Drug Administration. 21 Temmuz 2017. 17 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Ekim 2020.
"FDA strengthens warning of heart attack and stroke risk for non-steroidal anti-inflammatory drugs". U.S. Food and Drug Administration (FDA). 9 Temmuz 2015. 11 Temmuz 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Temmuz 2015.

frostburg.edu

antoine.frostburg.edu

"General chemistry online: FAQ: Acids and bases: What is the buffer system in buffered aspirin?". Antoine.frostburg.edu. 14 Nisan 2011 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Mayıs 2011.

genericides.org

"Has aspirin become a generic trademark?". genericides.org. 25 Mart 2020. 5 Mart 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 17 Şubat 2021.

guideline.gov

National Guideline Clearinghouse (NGC). "2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions". United States Agency for Healthcare Research and Quality (AHRQ). 13 Ağustos 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 28 Ağustos 2012.

handle.net

hdl.handle.net

Organization, World Health (2021). World Health Organization model list of essential medicines: 22nd list (2021). Cenevre: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Erqou S, Sattar N, ve diğerleri. (February 2012). "Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials". Archives of Internal Medicine. 172 (3). ss. 209-16. doi:10.1001/archinternmed.2011.628. hdl:10044/1/34287. PMID 22231610.
McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, ve diğerleri. (October 2018). "Effect of Aspirin on Disability-free Survival in the Healthy Elderly". The New England Journal of Medicine. 379 (16). ss. 1499-1508. doi:10.1056/NEJMoa1800722. hdl:1885/154654. PMC 6426126 $2. PMID 30221596.
Sofi F, Marcucci R, Gori AM, Abbate R, Gensini GF (August 2008). "Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events--a meta-analysis". International Journal of Cardiology. 128 (2). ss. 166-71. doi:10.1016/j.ijcard.2007.12.010. hdl:2158/323452. PMID 18242733.
del Río Solá ML, Antonio J, Fajardo G, Vaquero Puerta C (July 2012). "Influence of aspirin therapy in the ulcer associated with chronic venous insufficiency". Annals of Vascular Surgery. 26 (5). ss. 620-9. doi:10.1016/j.avsg.2011.02.051. hdl:10324/2904. PMID 22437068.

harvard.edu

adsabs.harvard.edu

Warner TD, Mitchell JA (October 2002). "Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?". Proceedings of the National Academy of Sciences of the United States of America. 99 (21). ss. 13371-3. Bibcode:2002PNAS...9913371W. doi:10.1073/pnas.222543099. PMC 129677 $2. PMID 12374850.
Hawley SA, Fullerton MD, Ross FA, Schertzer JD, Chevtzoff C, Walker KJ, ve diğerleri. (May 2012). "The ancient drug salicylate directly activates AMP-activated protein kinase". Science. 336 (6083). ss. 918-22. Bibcode:2012Sci...336..918H. doi:10.1126/science.1215327. PMC 3399766 $2. PMID 22517326.
Huth EJ, ve diğerleri. (CBE Style Manual Committee) (1994). Scientific style and format: the CBE manual for authors, editors, and publishers. Cambridge University Press. s. 164. Bibcode:1994ssfc.book.....S. ISBN 978-0-521-47154-1. 15 Ekim 2015 tarihinde kaynağından arşivlendi.
Fiorucci S, Santucci L, Wallace JL, Sardina M, Romano M, del Soldato P, ve diğerleri. (September 2003). "Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa". Proceedings of the National Academy of Sciences of the United States of America. 100 (19). ss. 10937-41. Bibcode:2003PNAS..10010937F. doi:10.1073/pnas.1933204100. PMC 196906 $2. PMID 12960371.
Doña I, Barrionuevo E, Salas M, Laguna JJ, Agúndez J, García-Martín E, ve diğerleri. (November 2018). "NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs". Scientific Reports. 8 (1). s. 16710. Bibcode:2018NatSR...816710D. doi:10.1038/s41598-018-34668-1. PMC 6232098 $2. PMID 30420763.

cyber.harvard.edu

"Bayer Co". cyber.harvard.edu. 29 Ağustos 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Aralık 2023.

healthychildren.org

"Medications Used to Treat Fever". American Academy of Pediatrics. 18 Şubat 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Kasım 2012.

iucr.org

reference.iucr.org

"Polytypism - Online Dictionary of Crystallography". reference.iucr.org. 3 Aralık 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.

jpp.krakow.pl

Raithel M, Baenkler HW, Naegel A, Buchwald F, Schultis HW, Backhaus B, ve diğerleri. (September 2005). "Significance of salicylate intolerance in diseases of the lower gastrointestinal tract" (PDF). Journal of Physiology and Pharmacology. 56 (Suppl 5). ss. 89-102. PMID 16247191. 9 Nisan 2011 tarihinde kaynağından arşivlendi (PDF).

legislation.gov.au

"Poisons Standard October 2022". Australian Government Federal Register of Legislation. 9 Ocak 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Ocak 2023.

mayoclinic.org

newsnetwork.mayoclinic.org

Torborg L (4 Aralık 2018). "Mayo Clinic Q and A: Coated aspirin may not be as effective at reducing blood clot risk". Mayo Clinic News Network. 15 Ocak 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.

medicinescomplete.com

Brayfield A, (Ed.) (14 Ocak 2014). "Aspirin". Martindale: The Complete Drug Reference. Pharmaceutical Press. 13 Temmuz 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Nisan 2014.
Baxter K, Preston CL ((Ed.)). "Aspirin and Spironolactone". MedicinesComplete: Stockley's Drug Interactions. Royal Pharmaceutical Society. 29 Mayıs 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.

medscape.com

reference.medscape.com

"Zorprin, Bayer Buffered Aspirin (aspirin) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. 7 Nisan 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Nisan 2014.

medscape.com

"Aspirin monograph: dosages, etc". Medscape.com. 13 Temmuz 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Mayıs 2011.

cme.medscape.com

"Aspirin: more evidence that low dose is all that is needed". Medscape. Medscape CME. 27 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Mayıs 2011.

misc.medscape.com

Kreplick LW (2001). "Salicylate toxicity in emergency medicine". Medscape. 31 Ağustos 2012 tarihinde kaynağından arşivlendi.

merckmanuals.com

"Analgesics (toxicity)". Merck. 11 Nisan 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Ocak 2018.

mercksource.com

"PDR guide to over the counter (OTC) drugs". 10 Nisan 2008 tarihinde kaynağından arşivlendi. Erişim tarihi: 28 Nisan 2008.

merckvetmanual.com

Edwards SH. "Nonsteroidal Anti-inflammatory Drugs: Aspirin". Merck Veterinary Manual. 18 Aralık 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 20 Ocak 2018.

mtak.hu

real.mtak.hu

Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK (August 2001). "Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation" (PDF). The New England Journal of Medicine. 345 (7). ss. 494-502. doi:10.1056/nejmoa010746. PMID 11519503. 6 Ocak 2022 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 10 Aralık 2023.

nhs.uk

"Reye's syndrome". NHS Choices. National Health Service. 12 Ocak 2016. 9 Ağustos 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.

nih.gov

ncbi.nlm.nih.gov

Warner TD, Mitchell JA (October 2002). "Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?". Proceedings of the National Academy of Sciences of the United States of America. 99 (21). ss. 13371-3. Bibcode:2002PNAS...9913371W. doi:10.1073/pnas.222543099. PMC 129677 $2. PMID 12374850.
Carstensen JT, Attarchi F (April 1988). "Decomposition of aspirin in the solid state in the presence of limited amounts of moisture III: Effect of temperature and a possible mechanism". Journal of Pharmaceutical Sciences. 77 (4). ss. 318-21. doi:10.1002/jps.2600770407. PMID 3379589.
Bučar DK, Lancaster RW, Bernstein J (June 2015). "Disappearing polymorphs revisited". Angewandte Chemie. 54 (24). ss. 6972-6993. doi:10.1002/anie.201410356. PMC 4479028 $2. PMID 26031248.
Vishweshwar P, McMahon JA, Oliveira M, Peterson ML, Zaworotko MJ (December 2005). "The predictably elusive form II of aspirin". Journal of the American Chemical Society. 127 (48). ss. 16802-16803. doi:10.1021/ja056455b. PMID 16316223.
Bond AD, Boese R, Desiraju GR (2007). "On the polymorphism of aspirin: crystalline aspirin as intergrowths of two "polymorphic" domains". Angewandte Chemie. 46 (4). ss. 618-622. doi:10.1002/anie.200603373. PMID 17139692.
Vane JR (June 1971). "Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs". Nature. 231 (25). ss. 232-5. doi:10.1038/newbio231232a0. PMID 5284360.
Vane JR, Botting RM (June 2003). "The mechanism of action of aspirin". Thrombosis Research. 110 (5–6). ss. 255-8. doi:10.1016/s0049-3848(03)00379-7. PMID 14592543.
Tohgi H, Konno S, Tamura K, Kimura B, Kawano K (October 1992). "Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin". Stroke. 23 (10). ss. 1400-3. doi:10.1161/01.STR.23.10.1400. PMID 1412574.
Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, ve diğerleri. (May 2009). "Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials". Lancet. 373 (9678). ss. 1849-60. doi:10.1016/S0140-6736(09)60503-1. PMC 2715005 $2. PMID 19482214.
Martínez-González J, Badimon L (2007). "Mechanisms underlying the cardiovascular effects of COX-inhibition: benefits and risks". Current Pharmaceutical Design. 13 (22). ss. 2215-27. doi:10.2174/138161207781368774. PMID 17691994.
Funk CD, FitzGerald GA (November 2007). "COX-2 inhibitors and cardiovascular risk". Journal of Cardiovascular Pharmacology. 50 (5). ss. 470-9. doi:10.1097/FJC.0b013e318157f72d. PMID 18030055.
Romano M, Cianci E, Simiele F, Recchiuti A (August 2015). "Lipoxins and aspirin-triggered lipoxins in resolution of inflammation". European Journal of Pharmacology. Cilt 760. ss. 49-63. doi:10.1016/j.ejphar.2015.03.083. PMID 25895638.
Serhan CN, Chiang N (August 2013). "Resolution phase lipid mediators of inflammation: agonists of resolution". Current Opinion in Pharmacology. 13 (4). ss. 632-40. doi:10.1016/j.coph.2013.05.012. PMC 3732499 $2. PMID 23747022.
Weylandt KH (August 2016). "Docosapentaenoic acid derived metabolites and mediators - The new world of lipid mediator medicine in a nutshell". European Journal of Pharmacology. Cilt 785. ss. 108-115. doi:10.1016/j.ejphar.2015.11.002. PMID 26546723.
Somasundaram S, Sigthorsson G, Simpson RJ, Watts J, Jacob M, Tavares IA, ve diğerleri. (May 2000). "Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat". Alimentary Pharmacology & Therapeutics. 14 (5). ss. 639-50. doi:10.1046/j.1365-2036.2000.00723.x. PMID 10792129.
Paul-Clark MJ, Van Cao T, Moradi-Bidhendi N, Cooper D, Gilroy DW (July 2004). "15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation". The Journal of Experimental Medicine. 200 (1). ss. 69-78. doi:10.1084/jem.20040566. PMC 2213311 $2. PMID 15238606.
McCarty MF, Block KI (September 2006). "Preadministration of high-dose salicylates, suppressors of NF-kappaB activation, may increase the chemosensitivity of many cancers: an example of proapoptotic signal modulation therapy". Integrative Cancer Therapies. 5 (3). ss. 252-68. doi:10.1177/1534735406291499. PMID 16880431.
Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, ve diğerleri. (January 2018). "Inflammatory responses and inflammation-associated diseases in organs". Oncotarget. 9 (6). ss. 7204-7218. doi:10.18632/oncotarget.23208. PMC 5805548 $2. PMID 29467962.
Lawrence T (December 2009). "The nuclear factor NF-kappaB pathway in inflammation". Cold Spring Harbor Perspectives in Biology. 1 (6). ss. a001651. doi:10.1101/cshperspect.a001651. PMC 2882124 $2. PMID 20457564.
Hawley SA, Fullerton MD, Ross FA, Schertzer JD, Chevtzoff C, Walker KJ, ve diğerleri. (May 2012). "The ancient drug salicylate directly activates AMP-activated protein kinase". Science. 336 (6083). ss. 918-22. Bibcode:2012Sci...336..918H. doi:10.1126/science.1215327. PMC 3399766 $2. PMID 22517326.
Alfonso LF, Srivenugopal KS, Arumugam TV, Abbruscato TJ, Weidanz JA, Bhat GJ (March 2009). "Aspirin inhibits camptothecin-induced p21CIP1 levels and potentiates apoptosis in human breast cancer cells". International Journal of Oncology. 34 (3). ss. 597-608. doi:10.3892/ijo_00000185. PMID 19212664.
Alfonso LF, Srivenugopal KS, Bhat GJ (2009). "Does aspirin acetylate multiple cellular proteins? (Review)". Molecular Medicine Reports. 2 (4). ss. 533-7. doi:10.3892/mmr_00000132. PMID 21475861.
Alfonso LF, Srivenugopal KS, Bhat GJ (4 Haziran 2009). "Does aspirin acetylate multiple cellular proteins? (Review)". Molecular Medicine Reports. 2 (4). ss. 533-537. doi:10.3892/mmr_00000132. PMID 21475861.
Ferguson RK, Boutros AR (August 1970). "Death following self-poisoning with aspirin". JAMA. 213 (7). ss. 1186-8. doi:10.1001/jama.213.7.1186. PMID 5468267.
Kaufman FL, Dubansky AS (April 1972). "Darvon poisoning with delayed salicylism: a case report". Pediatrics. 49 (4). ss. 610-1. doi:10.1542/peds.49.4.610. PMID 5013423.
Levy G, Tsuchiya T (August 1972). "Salicylate accumulation kinetics in man". The New England Journal of Medicine. 287 (9). ss. 430-2. doi:10.1056/NEJM197208312870903. PMID 5044917.
Grootveld M, Halliwell B (January 1988). "2,3-Dihydroxybenzoic acid is a product of human aspirin metabolism". Biochemical Pharmacology. 37 (2). ss. 271-80. doi:10.1016/0006-2952(88)90729-0. PMID 3342084.
Hartwig-Otto H (November 1983). "Pharmacokinetic considerations of common analgesics and antipyretics". The American Journal of Medicine. 75 (5A). ss. 30-7. doi:10.1016/0002-9343(83)90230-9. PMID 6606362.
Done AK (November 1960). "Salicylate intoxication. Significance of measurements of salicylate in blood in cases of acute ingestion". Pediatrics. Cilt 26. ss. 800-7. doi:10.1542/peds.26.5.800. PMID 13723722.
Chyka PA, Erdman AR, Christianson G, Wax PM, Booze LL, Manoguerra AS, ve diğerleri. (2007). "Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management". Clinical Toxicology. 45 (2). ss. 95-131. doi:10.1080/15563650600907140. PMID 17364628.
Prescott LF, Balali-Mood M, Critchley JA, Johnstone AF, Proudfoot AT (November 1982). "Diuresis or urinary alkalinisation for salicylate poisoning?". British Medical Journal. 285 (6352). ss. 1383-6. doi:10.1136/bmj.285.6352.1383. PMC 1500395 $2. PMID 6291695.
Dargan PI, Wallace CI, Jones AL (May 2002). "An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose". Emergency Medicine Journal. 19 (3). ss. 206-9. doi:10.1136/emj.19.3.206. PMC 1725844 $2. PMID 11971828.
D'Agati V (July 1996). "Does aspirin cause acute or chronic renal failure in experimental animals and in humans?". American Journal of Kidney Diseases. 28 (1 Suppl 1). ss. S24-9. doi:10.1016/s0272-6386(96)90565-x. PMID 8669425.
Schiebinger L (October 2003). "Women's health and clinical trials". The Journal of Clinical Investigation. 112 (7). ss. 973-7. doi:10.1172/JCI19993. PMC 198535 $2. PMID 14523031.
"Regular aspirin intake and acute myocardial infarction". British Medical Journal. 1 (5905). March 1974. ss. 440-3. doi:10.1136/bmj.1.5905.440. PMC 1633212 $2. PMID 4816857.
Elwood PC, Cochrane AL, Burr ML, Sweetnam PM, Williams G, Welsby E, ve diğerleri. (March 1974). "A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction". British Medical Journal. 1 (5905). ss. 436-40. doi:10.1136/bmj.1.5905.436. PMC 1633246 $2. PMID 4593555.
Cheng TO (2007). "The history of aspirin". Texas Heart Institute Journal. 34 (3). ss. 392-3. PMC 1995051 $2. PMID 17948100.
Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Erqou S, Sattar N, ve diğerleri. (February 2012). "Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials". Archives of Internal Medicine. 172 (3). ss. 209-16. doi:10.1001/archinternmed.2011.628. hdl:10044/1/34287. PMID 22231610.
McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, ve diğerleri. (October 2018). "Effect of Aspirin on Disability-free Survival in the Healthy Elderly". The New England Journal of Medicine. 379 (16). ss. 1499-1508. doi:10.1056/NEJMoa1800722. hdl:1885/154654. PMC 6426126 $2. PMID 30221596.
McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, ve diğerleri. (October 2018). "Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly". The New England Journal of Medicine. 379 (16). ss. 1509-1518. doi:10.1056/NEJMoa1805819. PMC 6289056 $2. PMID 30221597.
Algra AM, Rothwell PM (May 2012). "Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials". The Lancet. Oncology. 13 (5). ss. 518-27. doi:10.1016/S1470-2045(12)70112-2. PMID 22440112.
Davidson KW, Barry MJ, Mangione CM, Cabana M, Chelmow D, Coker TR, ve diğerleri. (April 2022). "Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement". JAMA. 327 (16). ss. 1577-1584. doi:10.1001/jama.2022.4983. PMID 35471505.
Sachs CJ (March 2005). "Oral analgesics for acute nonspecific pain". American Family Physician. 71 (5). ss. 913-8. PMID 15768621.
Gaciong Z (June 2003). "The real dimension of analgesic activity of aspirin". Thrombosis Research. 110 (5–6). ss. 361-4. doi:10.1016/j.thromres.2003.08.009. PMID 14592563.
Derry CJ, Derry S, Moore RA (December 2014). "Caffeine as an analgesic adjuvant for acute pain in adults". The Cochrane Database of Systematic Reviews. 2014 (12). ss. CD009281. doi:10.1002/14651858.CD009281.pub3. PMC 6485702 $2. PMID 25502052.
Hersh EV, Moore PA, Ross GL (May 2000). "Over-the-counter analgesics and antipyretics: a critical assessment". Clinical Therapeutics. 22 (5). ss. 500-48. doi:10.1016/S0149-2918(00)80043-0. PMID 10868553.
Mett A, Tfelt-Hansen P (June 2008). "Acute migraine therapy: recent evidence from randomized comparative trials". Current Opinion in Neurology. 21 (3). ss. 331-7. doi:10.1097/WCO.0b013e3282fee843. PMID 18451718.
Kingery WS (November 1997). "A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes". Pain. 73 (2). ss. 123-139. doi:10.1016/S0304-3959(97)00049-3. PMID 9415498.
Loder E, Rizzoli P (January 2008). "Tension-type headache". BMJ. 336 (7635). ss. 88-92. doi:10.1136/bmj.39412.705868.AD. PMC 2190284 $2. PMID 18187725.
Gilmore B, Michael M (February 2011). "Treatment of acute migraine headache". American Family Physician. 83 (3). ss. 271-80. PMID 21302868.
Bartfai T, Conti B (March 2010). "Fever". TheScientificWorldJournal. Cilt 10. ss. 490-503. doi:10.1100/tsw.2010.50. PMC 2850202 $2. PMID 20305990.
Pugliese A, Beltramo T, Torre D (October 2008). "Reye's and Reye's-like syndromes". Cell Biochemistry and Function. 26 (7). ss. 741-6. doi:10.1002/cbf.1465. PMID 18711704.
Beutler AI, Chesnut GT, Mattingly JC, Jamieson B (December 2009). "FPIN's Clinical Inquiries. Aspirin use in children for fever or viral syndromes". American Family Physician. 80 (12). s. 1472. PMID 20000310.
Morris T, Stables M, Hobbs A, de Souza P, Colville-Nash P, Warner T, ve diğerleri. (August 2009). "Effects of low-dose aspirin on acute inflammatory responses in humans". Journal of Immunology. 183 (3). ss. 2089-96. doi:10.4049/jimmunol.0900477. PMID 19597002.
National Clinical Guideline Centre (UK) (July 2013). "Adjunctive pharmacotherapy and associated NICE guidance". Myocardial infarction with ST-segment elevation: the acute management of myocardial infarction with ST-segment elevation [Internet]. NICE Clinical Guidelines. 17.2 Aspirin: Royal College of Physicians (UK). PMID 25340241. 31 Aralık 2015 tarihinde kaynağından arşivlendi.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, ve diğerleri. (September 2019). "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Journal of the American College of Cardiology. 74 (10). ss. e177-e232. doi:10.1016/j.jacc.2019.03.010. PMC 7685565 $2. PMID 30894318.
Rothwell PM, Cook NR, Gaziano JM, Price JF, Belch JF, Roncaglioni MC, ve diğerleri. (August 2018). "Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials". Lancet. 392 (10145). ss. 387-399. doi:10.1016/S0140-6736(18)31133-4. PMC 6083400 $2. PMID 30017552.
Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, Barton J, ve diğerleri. (October 2018). "Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus". The New England Journal of Medicine. 379 (16). ss. 1529-1539. doi:10.1056/NEJMoa1804988. PMID 30146931.
Woods RL, Polekhina G, Wolfe R, Nelson MR, Ernst ME, Reid CM, ve diğerleri. (March 2020). "No Modulation of the Effect of Aspirin by Body Weight in Healthy Older Men and Women". Circulation. 141 (13). ss. 1110-1112. doi:10.1161/CIRCULATIONAHA.119.044142. PMC 7286412 $2. PMID 32223674.
Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK (August 2001). "Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation" (PDF). The New England Journal of Medicine. 345 (7). ss. 494-502. doi:10.1056/nejmoa010746. PMID 11519503. 6 Ocak 2022 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 10 Aralık 2023.
Costa F, Vranckx P, Leonardi S, Moscarella E, Ando G, Calabro P, ve diğerleri. (May 2015). "Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial". European Heart Journal. 36 (20). ss. 1242-51. doi:10.1016/s0735-1097(15)61590-x . PMID 25718355.
Khan SU, Singh M, Valavoor S, Khan MU, Lone AN, Khan MZ, ve diğerleri. (October 2020). "Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis". Circulation. 142 (15). ss. 1425-1436. doi:10.1161/CIRCULATIONAHA.120.046308. PMC 7547897 $2. PMID 32795096.
Capodanno D, Alfonso F, Levine GN, Valgimigli M, Angiolillo DJ (December 2018). "ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison". Journal of the American College of Cardiology. 72 (23 Pt A). ss. 2915-2931. doi:10.1016/j.jacc.2018.09.057. PMID 30522654.
Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, ve diğerleri. (September 2016). "2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Journal of the American College of Cardiology. 68 (10). ss. 1082-115. doi:10.1016/j.jacc.2016.03.513. PMID 27036918.
Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, ve diğerleri. (January 2018). "2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)". European Heart Journal. 39 (3). ss. 213-260. doi:10.1093/eurheartj/ehx419. PMID 28886622.
Visseren FL, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, ve diğerleri. (September 2021). "2021 ESC Guidelines on cardiovascular disease prevention in clinical practice". European Heart Journal. 42 (34). ss. 3227-3337. doi:10.1093/eurheartj/ehab484. PMID 34458905.
Norris JW (September 2005). "Antiplatelet agents in secondary prevention of stroke: a perspective". Stroke. 36 (9). ss. 2034-6. doi:10.1161/01.STR.0000177887.14339.46. PMID 16100022.
Sleight P, Pouleur H, Zannad F (July 2006). "Benefits, challenges, and registerability of the polypill". European Heart Journal. 27 (14). ss. 1651-6. doi:10.1093/eurheartj/ehi841. PMID 16603580.
Wang TH, Bhatt DL, Topol EJ (March 2006). "Aspirin and clopidogrel resistance: an emerging clinical entity". European Heart Journal. 27 (6). ss. 647-54. doi:10.1093/eurheartj/ehi684. PMID 16364973.
Oliveira DC, Silva RF, Silva DJ, Lima VC (September 2010). "Aspirin resistance: fact or fiction?". Arquivos Brasileiros de Cardiologia. 95 (3). ss. e91-4. doi:10.1590/S0066-782X2010001300024. PMID 20944898.
Topçuoglu MA, Arsava EM, Ay H (February 2011). "Antiplatelet resistance in stroke". Expert Review of Neurotherapeutics. 11 (2). ss. 251-63. doi:10.1586/ern.10.203. PMC 3086673 $2. PMID 21306212.
Ben-Dor I, Kleiman NS, Lev E (July 2009). "Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy". The American Journal of Cardiology. 104 (2). ss. 227-33. doi:10.1016/j.amjcard.2009.03.022. PMID 19576352.
Davidson KW, Barry MJ, Mangione CM, Cabana M, Chelmow D, Coker TR, ve diğerleri. (April 2022). "Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement". JAMA. 327 (16). ss. 1577-1584. doi:10.1001/jama.2022.4983. PMID 35471505.
Cuzick J, Thorat MA, Bosetti C, Brown PH, Burn J, Cook NR, ve diğerleri. (January 2015). "Estimates of benefits and harms of prophylactic use of aspirin in the general population". Annals of Oncology. 26 (1). ss. 47-57. doi:10.1093/annonc/mdu225. PMC 4269341 $2. PMID 25096604.
Manzano A, Pérez-Segura P (29 Nisan 2012). "Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?". TheScientificWorldJournal. Cilt 2012. s. 327341. doi:10.1100/2012/327341. PMC 3353298 $2. PMID 22649288.
Chan AT, Arber N, Burn J, Chia WK, Elwood P, Hull MA, ve diğerleri. (February 2012). "Aspirin in the chemoprevention of colorectal neoplasia: an overview". Cancer Prevention Research. 5 (2). ss. 164-78. doi:10.1158/1940-6207.CAPR-11-0391. PMC 3273592 $2. PMID 22084361.
Thun MJ, Jacobs EJ, Patrono C (April 2012). "The role of aspirin in cancer prevention". Nature Reviews. Clinical Oncology. 9 (5). ss. 259-67. doi:10.1038/nrclinonc.2011.199. PMID 22473097.
Richman IB, Owens DK (July 2017). "Aspirin for Primary Prevention". The Medical Clinics of North America. 101 (4). ss. 713-724. doi:10.1016/j.mcna.2017.03.004. PMID 28577622.
Verdoodt F, Friis S, Dehlendorff C, Albieri V, Kjaer SK (February 2016). "Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: A systematic review and meta-analysis of observational studies". Gynecologic Oncology. 140 (2). ss. 352-8. doi:10.1016/j.ygyno.2015.12.009. PMID 26701413.
Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C (June 2012). "Aspirin and cancer risk: a quantitative review to 2011". Annals of Oncology. 23 (6). ss. 1403-15. doi:10.1093/annonc/mds113. PMID 22517822.
Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Kandala NB, ve diğerleri. (September 2013). "Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews". Health Technology Assessment. 17 (43). ss. 1-253. doi:10.3310/hta17430. PMC 4781046 $2. PMID 24074752.
Kim SE (2014). "The benefit-risk consideration in long-term use of alternate-day, low dose aspirin: focus on colorectal cancer prevention". Annals of Gastroenterology. 27 (1). ss. 87-88. PMC 3959543 $2. PMID 24714632.
U.S. Preventive Services Task Force (March 2007). "Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement". Annals of Internal Medicine. 146 (5). ss. 361-4. doi:10.7326/0003-4819-146-5-200703060-00008. PMID 17339621.
Bibbins-Domingo K (June 2016). "Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement". Annals of Internal Medicine. 164 (12). ss. 836-45. doi:10.7326/m16-0577. PMID 27064677.
Bosetti C, Santucci C, Gallus S, Martinetti M, La Vecchia C (May 2020). "Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019". Annals of Oncology. 31 (5). ss. 558-568. doi:10.1016/j.annonc.2020.02.012. PMID 32272209. The present comprehensive meta-analysis supports and further quantifies the inverse association between regular aspirin use and the risk of colorectal and other digestive tract cancers, including some rare ones. The favorable effect of aspirin increases with longer duration of use, and, for colorectal cancer, with increasing dose.
McNeil JJ, Nelson MR, Woods RL, Lockery JE, Wolfe R, Reid CM, ve diğerleri. (October 2018). "Effect of Aspirin on All-Cause Mortality in the Healthy Elderly". The New England Journal of Medicine. 379 (16). ss. 1519-1528. doi:10.1056/NEJMoa1803955. PMC 6433466 $2. PMID 30221595.
Bartoli F, Cavaleri D, Bachi B, Moretti F, Riboldi I, Crocamo C, Carrà G (November 2021). "Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials". Journal of Psychiatric Research. Cilt 143. ss. 230-238. doi:10.1016/j.jpsychires.2021.09.018. PMID 34509090.
Dominiak M, Gędek A, Sikorska M, Mierzejewski P, Wojnar M, Antosik-Wójcińska AZ (December 2022). "Acetylsalicylic Acid and Mood Disorders: A Systematic Review". Pharmaceuticals. 16 (1). s. 67. doi:10.3390/ph16010067. PMC 9861965 $2. PMID 36678565.
Savitz JB, Teague TK, Misaki M, Macaluso M, Wurfel BE, Meyer M, ve diğerleri. (January 2018). "Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial". Translational Psychiatry. 8 (1). s. 27. doi:10.1038/s41398-017-0073-7. PMC 5802452 $2. PMID 29362444.
Bauer IE, Green C, Colpo GD, Teixeira AL, Selvaraj S, Durkin K, ve diğerleri. (December 2018). "A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression". The Journal of Clinical Psychiatry. 80 (1). doi:10.4088/JCP.18m12200. PMID 30549489.
Li H, Li W, Zhang X, Ma XC, Zhang RW (4 Şubat 2021). "Aspirin Use on Incident Dementia and Mild Cognitive Decline: A Systematic Review and Meta-Analysis". Frontiers in Aging Neuroscience. Cilt 12. s. 578071. doi:10.3389/fnagi.2020.578071. PMC 7890199 $2. PMID 33613260.
Veronese N, Stubbs B, Maggi S, Thompson T, Schofield P, Muller C, ve diğerleri. (August 2017). "Low-Dose Aspirin Use and Cognitive Function in Older Age: A Systematic Review and Meta-analysis". Journal of the American Geriatrics Society. 65 (8). ss. 1763-1768. doi:10.1111/jgs.14883. PMC 6810633 $2. PMID 28425093.
Schmidt L, Phelps E, Friedel J, Shokraneh F (August 2019). "Acetylsalicylic acid (aspirin) for schizophrenia". The Cochrane Database of Systematic Reviews. 2019 (8). ss. CD012116. doi:10.1002/14651858.CD012116.pub2. PMC 6699651 $2. PMID 31425623.
Fond G, Lançon C, Korchia T, Auquier P, Boyer L (2020). "The Role of Inflammation in the Treatment of Schizophrenia". Frontiers in Psychiatry. Cilt 11. s. 160. doi:10.3389/fpsyt.2020.00160. PMC 7093323 $2. PMID 32256401.
Saxena A, Kumar RK, Gera RP, Radhakrishnan S, Mishra S, Ahmed Z (July 2008). "Consensus guidelines on pediatric acute rheumatic fever and rheumatic heart disease". Indian Pediatrics. 45 (7). ss. 565-73. PMID 18695275.
Hashkes PJ, Tauber T, Somekh E, Brik R, Barash J, Mukamel M, ve diğerleri. (September 2003). "Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial". The Journal of Pediatrics. 143 (3). ss. 399-401. doi:10.1067/S0022-3476(03)00388-3. PMID 14517527.
Rowley AH, Shulman ST (February 2010). "Pathogenesis and management of Kawasaki disease". Expert Review of Anti-Infective Therapy. 8 (2). ss. 197-203. doi:10.1586/eri.09.109. PMC 2845298 $2. PMID 20109049.
Baumer JH, Love SJ, Gupta A, Haines LC, Maconochie I, Dua JS (October 2006). "Salicylate for the treatment of Kawasaki disease in children". The Cochrane Database of Systematic Reviews. 2010 (4). ss. CD004175. doi:10.1002/14651858.CD004175.pub2. PMC 8765111 $2. PMID 17054199.
Duley L, Meher S, Hunter KE, Seidler AL, Askie LM (October 2019). "Antiplatelet agents for preventing pre-eclampsia and its complications". The Cochrane Database of Systematic Reviews. 2019 (10). doi:10.1002/14651858.CD004659.pub3. PMC 6820858 $2. PMID 31684684.
Roberge S, Villa P, Nicolaides K, Giguère Y, Vainio M, Bakthi A, ve diğerleri. (2012). "Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis". Fetal Diagnosis and Therapy. 31 (3). ss. 141-6. doi:10.1159/000336662. PMID 22441437.
Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E (February 2017). "The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis". American Journal of Obstetrics and Gynecology. 216 (2). ss. 110-120.e6. doi:10.1016/j.ajog.2016.09.076. PMID 27640943.
Szabó B, Németh K, Mészáros K, Krokker L, Likó I, Saskői E, ve diğerleri. (5 Eylül 2022). "Aspirin Mediates Its Antitumoral Effect Through Inhibiting PTTG1 in Pituitary Adenoma". The Journal of Clinical Endocrinology and Metabolism. 107 (11). ss. 3066-3079. doi:10.1210/clinem/dgac496. PMC 9681612 $2. PMID 36059148.
Dorsch MP, Lee JS, Lynch DR, Dunn SP, Rodgers JE, Schwartz T, ve diğerleri. (May 2007). "Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction". The Annals of Pharmacotherapy. 41 (5). ss. 737-41. doi:10.1345/aph.1H621. PMID 17456544.
Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR (January 2008). "Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis". BMJ. 336 (7637). ss. 195-8. doi:10.1136/bmj.39430.529549.BE. PMC 2213873 $2. PMID 18202034.
Pignatelli P, Di Santo S, Barillà F, Gaudio C, Violi F (October 2008). "Multiple anti-atherosclerotic treatments impair aspirin compliance: effects on aspirin resistance". Journal of Thrombosis and Haemostasis. 6 (10). ss. 1832-4. doi:10.1111/j.1538-7836.2008.03122.x. PMID 18680540.
Grosser T, Fries S, Lawson JA, Kapoor SC, Grant GR, FitzGerald GA (January 2013). "Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin". Circulation. 127 (3). ss. 377-85. doi:10.1161/CIRCULATIONAHA.112.117283. PMC 3552520 $2. PMID 23212718.
Li J, Song M, Jian Z, Guo W, Chen G, Jiang G, ve diğerleri. (2014). "Laboratory aspirin resistance and the risk of major adverse cardiovascular events in patients with coronary heart disease on confirmed aspirin adherence". Journal of Atherosclerosis and Thrombosis. 21 (3). ss. 239-47. doi:10.5551/jat.19521. PMID 24201035.
Sofi F, Marcucci R, Gori AM, Abbate R, Gensini GF (August 2008). "Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events--a meta-analysis". International Journal of Cardiology. 128 (2). ss. 166-71. doi:10.1016/j.ijcard.2007.12.010. hdl:2158/323452. PMID 18242733.
Shim EJ, Ryu CW, Park S, Lee HN, Shin HS, Kim SB (October 2018). "Relationship between adverse events and antiplatelet drug resistance in neurovascular intervention: a meta-analysis". Journal of NeuroInterventional Surgery. 10 (10). ss. 942-948. doi:10.1136/neurintsurg-2017-013632. PMID 29352056.
Fiolaki A, Katsanos AH, Kyritsis AP, Papadaki S, Kosmidou M, Moschonas IC, ve diğerleri. (May 2017). "High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: A systematic review and meta-analysis". Journal of the Neurological Sciences. Cilt 376. ss. 112-116. doi:10.1016/j.jns.2017.03.010. PMID 28431593.
Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Huisman MV (13 Ağustos 2007). "Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis". Archives of Internal Medicine. 167 (15). ss. 1593-9. doi:10.1001/archinte.167.15.1593. PMID 17698681.
van Oosterom N, Barras M, Bird R, Nusem I, Cottrell N (December 2020). "A Narrative Review of Aspirin Resistance in VTE Prophylaxis for Orthopaedic Surgery". Drugs. 80 (18). ss. 1889-1899. doi:10.1007/s40265-020-01413-w. PMID 33037568.
US Preventive Services Task Force (March 2009). "Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement". Annals of Internal Medicine. 150 (6). ss. 396-404. doi:10.7326/0003-4819-150-6-200903170-00008. PMID 19293072.
Berger JS, Brown DL, Burke GL, Oberman A, Kostis JB, Langer RD, ve diğerleri. (March 2009). "Aspirin Use, Dose, and Clinical Outcomes in Postmenopausal Women With Stable Cardiovascular Disease". Circulation: Cardiovascular Quality and Outcomes. 2 (2). ss. 78-87. doi:10.1161/circoutcomes.108.791269. ISSN 1941-7713. PMC 2801891 $2. PMID 20031819.
Sacristán JA (August 2021). "Aspirin Dosing in Cardiovascular Disease". New England Journal of Medicine. 385 (8). ss. 764-765. doi:10.1056/nejmc2110476. ISSN 0028-4793. PMID 34407352.
Raithel M, Baenkler HW, Naegel A, Buchwald F, Schultis HW, Backhaus B, ve diğerleri. (September 2005). "Significance of salicylate intolerance in diseases of the lower gastrointestinal tract" (PDF). Journal of Physiology and Pharmacology. 56 (Suppl 5). ss. 89-102. PMID 16247191. 9 Nisan 2011 tarihinde kaynağından arşivlendi (PDF).
Senna GE, Andri G, Dama AR, Mezzelani P, Andri L (1995). "Tolerability of imidazole salycilate in aspirin-sensitive patients". Allergy Proceedings. 16 (5). ss. 251-254. doi:10.2500/108854195778702675. PMID 8566739.
Zhang Y, Neogi T, Chen C, Chaisson C, Hunter DJ, Choi H (February 2014). "Low-dose aspirin use and recurrent gout attacks". Annals of the Rheumatic Diseases. 73 (2). ss. 385-390. doi:10.1136/annrheumdis-2012-202589. PMC 3902644 $2. PMID 23345599.
Polkinghorne KR, Wetmore JB, Thao LT, Wolfe R, Woods RL, Ernst ME, ve diğerleri. (December 2022). "Effect of Aspirin on CKD Progression in Older Adults: Secondary Analysis From the ASPREE Randomized Clinical Trial". American Journal of Kidney Diseases. 80 (6). ss. 810-813. doi:10.1053/j.ajkd.2022.02.019. PMC 9562592 $2. PMID 35430328.
Mann JF, Joseph P, Gao P, Pais P, Tyrwhitt J, Xavier D, ve diğerleri. (February 2023). "Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease". Kidney International. 103 (2). ss. 403-410. doi:10.1016/j.kint.2022.09.023. PMID 36341885.
Macdonald S (November 2002). "Aspirin use to be banned in under 16 year olds". BMJ. 325 (7371). ss. 988c-988. doi:10.1136/bmj.325.7371.988/c. PMC 1169585 $2. PMID 12411346.
Sørensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, Olsen JH (September 2000). "Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin". The American Journal of Gastroenterology. 95 (9). ss. 2218-2224. doi:10.1016/s0002-9270(00)01040-6. PMID 11007221.
Kedir HM, Sisay EA, Abiye AA (2021). "Enteric-Coated Aspirin and the Risk of Gastrointestinal Side Effects: A Systematic Review". International Journal of General Medicine. Cilt 14. ss. 4757-4763. doi:10.2147/ijgm.s326929. PMC 8403009 $2. PMID 34466020.
Cox D, Maree AO, Dooley M, Conroy R, Byrne MF, Fitzgerald DJ (August 2006). "Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers". Stroke. 37 (8). ss. 2153-2158. doi:10.1161/01.STR.0000231683.43347.ec. PMID 16794200.
Delaney JA, Opatrny L, Brophy JM, Suissa S (August 2007). "Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding". CMAJ. 177 (4). ss. 347-351. doi:10.1503/cmaj.070186. PMC 1942107 $2. PMID 17698822.
Wallace JL (October 2008). "Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?". Physiological Reviews. 88 (4). ss. 1547-65. doi:10.1152/physrev.00004.2008. PMID 18923189.
Laine L, Maller ES, Yu C, Quan H, Simon T (August 2004). "Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial". Gastroenterology. 127 (2). ss. 395-402. doi:10.1053/j.gastro.2004.05.001. PMID 15300570.
Fiorucci S, Santucci L, Wallace JL, Sardina M, Romano M, del Soldato P, ve diğerleri. (September 2003). "Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa". Proceedings of the National Academy of Sciences of the United States of America. 100 (19). ss. 10937-41. Bibcode:2003PNAS..10010937F. doi:10.1073/pnas.1933204100. PMC 196906 $2. PMID 12960371.
Rostom A, Muir K, Dubé C, Jolicoeur E, Boucher M, Joyce J, ve diğerleri. (July 2007). "Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review". Clinical Gastroenterology and Hepatology. 5 (7). ss. 818-28, 828.e1-5; quiz 768. doi:10.1016/j.cgh.2007.03.011. PMID 17556027.
Davison C, Smith BW, Smith PK (August 1962). "Effects of buffered and unbuffered acetylsalicylic acid upon the gastric acidity of normal human subjects". Journal of Pharmaceutical Sciences. 51 (8). ss. 759-763. doi:10.1002/jps.2600510813. PMID 13883982.
Dammann HG, Saleki M, Torz M, Schulz HU, Krupp S, Schürer M, ve diğerleri. (February 2004). "Effects of buffered and plain acetylsalicylic acid formulations with and without ascorbic acid on gastric mucosa in healthy subjects". Alimentary Pharmacology & Therapeutics. 19 (3). ss. 367-74. doi:10.1111/j.1365-2036.2004.01742.x. PMID 14984384.
Konturek PC, Kania J, Hahn EG, Konturek JW (November 2006). "Ascorbic acid attenuates aspirin-induced gastric damage: role of inducible nitric oxide synthase". Journal of Physiology and Pharmacology. 57 (Suppl 5). ss. 125-36. PMID 17218764.
Hayreh SS (July 2014). "Ocular vascular occlusive disorders: natural history of visual outcome". Progress in Retinal and Eye Research. Cilt 41. ss. 1-25. doi:10.1016/j.preteyeres.2014.04.001. PMC 4073304 $2. PMID 24769221.
Ageno W, Beyer-Westendorf J, Garcia DA, Lazo-Langner A, McBane RD, Paciaroni M (January 2016). "Guidance for the management of venous thrombosis in unusual sites". Journal of Thrombosis and Thrombolysis. 41 (1). ss. 129-43. doi:10.1007/s11239-015-1308-1. PMC 4715841 $2. PMID 26780742.
Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A, Schonberger LB (May 1999). "Reye's syndrome in the United States from 1981 through 1997". The New England Journal of Medicine. 340 (18). ss. 1377-82. doi:10.1056/NEJM199905063401801. PMID 10228187.
Doña I, Barrionuevo E, Salas M, Laguna JJ, Agúndez J, García-Martín E, ve diğerleri. (November 2018). "NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs". Scientific Reports. 8 (1). s. 16710. Bibcode:2018NatSR...816710D. doi:10.1038/s41598-018-34668-1. PMC 6232098 $2. PMID 30420763.
Kowalski ML, Agache I, Bavbek S, Bakirtas A, Blanca M, Bochenek G, ve diğerleri. (January 2019). "Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper". Allergy. 74 (1). ss. 28-39. doi:10.1111/all.13599. PMID 30216468.
Sánchez-Borges M, Capriles-Hulett A (January 2000). "Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity". Annals of Allergy, Asthma & Immunology. 84 (1). ss. 101-6. doi:10.1016/S1081-1206(10)62748-2. PMID 10674573.
Stadelmann WK, Digenis AG, Tobin GR (August 1998). "Impediments to wound healing". American Journal of Surgery. 176 (2A Suppl). ss. 39S-47S. doi:10.1016/S0002-9610(98)00184-6. PMID 9777971.
Layton AM, Ibbotson SH, Davies JA, Goodfield MJ (July 1994). "Randomised trial of oral aspirin for chronic venous leg ulcers". Lancet. 344 (8916). ss. 164-5. doi:10.1016/s0140-6736(94)92759-6. PMID 7912767.
del Río Solá ML, Antonio J, Fajardo G, Vaquero Puerta C (July 2012). "Influence of aspirin therapy in the ulcer associated with chronic venous insufficiency". Annals of Vascular Surgery. 26 (5). ss. 620-9. doi:10.1016/j.avsg.2011.02.051. hdl:10324/2904. PMID 22437068.
de Oliveira Carvalho PE, Magolbo NG, De Aquino RF, Weller CD, ve diğerleri. (Cochrane Wounds Group) (February 2016). "Oral aspirin for treating venous leg ulcers". The Cochrane Database of Systematic Reviews. 2016 (2). ss. CD009432. doi:10.1002/14651858.CD009432.pub2. PMC 8627253 $2. PMID 26889740.
Jull A, Wadham A, Bullen C, Parag V, Kerse N, Waters J (November 2017). "Low dose aspirin as adjuvant treatment for venous leg ulceration: pragmatic, randomised, double blind, placebo controlled trial (Aspirin4VLU)". BMJ. Cilt 359. ss. j5157. doi:10.1136/bmj.j5157. PMC 5701114 $2. PMID 29175902.
Tilbrook H, Clark L, Cook L, Bland M, Buckley H, Chetter I, ve diğerleri. (October 2018). "AVURT: aspirin versus placebo for the treatment of venous leg ulcers - a Phase II pilot randomised controlled trial". Health Technology Assessment. 22 (55). ss. 1-138. doi:10.3310/hta22550. PMC 6204573 $2. PMID 30325305.
Berges-Gimeno MP, Stevenson DD (June 2004). "Nonsteroidal anti-inflammatory drug-induced reactions and desensitization". The Journal of Asthma. 41 (4). ss. 375-84. doi:10.1081/JAS-120037650. PMID 15281324.
Vernooij MW, Haag MD, van der Lugt A, Hofman A, Krestin GP, Stricker BH, ve diğerleri. (June 2009). "Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study". Archives of Neurology. 66 (6). ss. 714-20. doi:10.1001/archneurol.2009.42. PMID 19364926.
Gorelick PB (June 2009). "Cerebral microbleeds: evidence of heightened risk associated with aspirin use". Archives of Neurology. 66 (6). ss. 691-3. doi:10.1001/archneurol.2009.85. PMID 19506128.
He J, Whelton PK, Vu B, Klag MJ (December 1998). "Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials". JAMA. 280 (22). ss. 1930-5. doi:10.1001/jama.280.22.1930. PMID 9851479.
Saloheimo P, Ahonen M, Juvela S, Pyhtinen J, Savolainen ER, Hillbom M (January 2006). "Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death". Stroke. 37 (1). ss. 129-33. doi:10.1161/01.STR.0000196991.03618.31. PMID 16322483.
Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, ve diğerleri. (November 2006). "A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease". European Heart Journal. 27 (22). ss. 2667-2674. doi:10.1093/eurheartj/ehl334. PMID 17053008.
Gaudreault P, Temple AR, Lovejoy FH (October 1982). "The relative severity of acute versus chronic salicylate poisoning in children: a clinical comparison". Pediatrics. 70 (4). ss. 566-9. doi:10.1542/peds.70.4.566. PMID 7122154.
Morra P, Bartle WR, Walker SE, Lee SN, Bowles SK, Reeves RA (September 1996). "Serum concentrations of salicylic acid following topically applied salicylate derivatives". The Annals of Pharmacotherapy. 30 (9). ss. 935-40. doi:10.1177/106002809603000903. PMID 8876850.
Alqahtani Z, Jamali F (2018). "Clinical Outcomes of Aspirin Interaction with Other Non-Steroidal Anti-Inflammatory Drugs: A Systematic Review". Journal of Pharmacy & Pharmaceutical Sciences. 21 (1s). ss. 48s-73s. doi:10.18433/jpps29854. PMID 29891025.
Gladding PA, Webster MW, Farrell HB, Zeng IS, Park R, Ruijne N (April 2008). "The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers". The American Journal of Cardiology. 101 (7). ss. 1060-1063. doi:10.1016/j.amjcard.2007.11.054. PMID 18359332.
Hollifield JW (August 1976). "Failure of aspirin to antagonize the antihypertensive effect of spironolactone in low-renin hypertension". Southern Medical Journal. 69 (8). ss. 1034-6. doi:10.1097/00007611-197608000-00022. PMID 785608.
Loh HS, Watters K, Wilson CW (1 Kasım 1973). "The effects of aspirin on the metabolic availability of ascorbic acid in human beings". Journal of Clinical Pharmacology. 13 (11). ss. 480-486. doi:10.1002/j.1552-4604.1973.tb00203.x. PMID 4490672.
Basu TK (1982). "Vitamin C-aspirin interactions". International Journal for Vitamin and Nutrition Research. Supplement. Cilt 23. ss. 83-90. PMID 6811490.
Ioannides C, Stone AN, Breacker PJ, Basu TK (December 1982). "Impairment of absorption of ascorbic acid following ingestion of aspirin in guinea pigs". Biochemical Pharmacology. 31 (24). ss. 4035-4038. doi:10.1016/0006-2952(82)90652-9. PMID 6818974.
"Randomised Trial of Intravenous Streptokinase, Oral Aspirin, Both, or Neither Among 17,187 Cases of Suspected Acute Myocardial Infarction: Isis-2". The Lancet. 332 (8607). August 1988. ss. 349-360. doi:10.1016/s0140-6736(88)92833-4. ISSN 0140-6736. PMID 2899772.
Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, ve diğerleri. (August 1983). "Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study". New England Journal of Medicine. 309 (7). ss. 396-403. doi:10.1056/NEJM198308183090703. ISSN 0028-4793. PMID 6135989.
Di Bella S, Luzzati R, Principe L, Zerbato V, Meroni E, Giuffrè M, ve diğerleri. (25 Ocak 2022). "Aspirin and Infection: A Narrative Review". Biomedicines. 10 (2). s. 263. doi:10.3390/biomedicines10020263. ISSN 2227-9059. PMC 8868581 $2. PMID 35203473.
Cao Y, Tan A (September 2020). "Aspirin might reduce the incidence of breast cancer: An updated meta-analysis of 38 observational studies". Medicine. 99 (38). ss. e21917. doi:10.1097/md.0000000000021917. PMC 7505405 $2. PMID 32957311.
Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, ve diğerleri. (July 2005). "Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial". JAMA. 294 (1). ss. 47-55. doi:10.1001/jama.294.1.47. PMID 15998890.

pubchem.ncbi.nlm.nih.gov

PubChem'den CID 2244

nobelprize.org

"The Nobel Prize in Physiology or Medicine 1982". Nobelprize.org. 27 Haziran 2017 tarihinde kaynağından arşivlendi.

npr.org

Aubrey A, Stone W (26 Nisan 2022). "Older adults shouldn't start a routine of daily aspirin, task force says". NPR. 5 Mayıs 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.

personalmd.com

"Oral Aspirin information". First DataBank. 18 Eylül 2000 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Mayıs 2008.

pharmacopoeia.co.uk

"Index BP 2009" (PDF). British Pharmacopoeia. 11 Nisan 2009 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 13 Temmuz 2009.

racgp.org.au

National Heart Foundation of Australia (RF/RHD guideline development working group) and the Cardiac Society of Australia and New Zealand (2006). "Diagnosis and management of acute rheumatic fever and rheumatic heart disease in Australia. An evidence-based review" (PDF). National Heart Foundation of Australia. ss. 33-37. 26 Temmuz 2008 tarihinde kaynağından (PDF) arşivlendi.

sciencehistory.org

Dick B (2018). "Hard Work and Happenstance". Distillations. 4 (1). Science History Institute. ss. 44-45. 12 Kasım 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.
Goldberg DR (Yaz 2009). "Aspirin: Turn of the Century Miracle Drug". Chemical Heritage. 27 (2). ss. 26-30. 20 Mart 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.

sigmaaldrich.com

"Aspirin". Sigma Aldrich. 24 Ocak 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Ocak 2022.

tga.gov.au

"OTC medicine monograph: Aspirin tablets for oral use". Therapeutic Goods Administration (TGA). 21 Haziran 2022. 30 Mart 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 4 Nisan 2023.

theguardian.com

amp.theguardian.com

"Gardens: drug therapy for plants | Gardening advice". The Guardian. 29 Mayıs 2022 tarihinde kaynağından arşivlendi.

tut.ac.jp

chrom.tutms.tut.ac.jp

"Acetylsalicylic acid". Jinno Laboratory, School of Materials Science, Toyohashi University of Technology. 4 Mart 1996. 20 Ocak 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 12 Nisan 2014.

unt.edu

cybercemetery.unt.edu

"Aspirin Water Helps Plants". cybercemetery.unt.edu. 2 Nisan 2023 tarihinde kaynağından arşivlendi.

usda.gov

ars.usda.gov

"Priming Plant Defenses with Aspirin-like Compound : USDA ARS". www.ars.usda.gov. 19 Mayıs 2022 tarihinde kaynağından arşivlendi.

uspreventiveservicestaskforce.org

Bu madde bu kaynaktan gelen kamu malı içermektedir: "Aspirin for the prevention of cardiovascular disease". U.S. Preventive Services Task Force. 11 Temmuz 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Temmuz 2012.
Bu madde bu kaynaktan gelen kamu malı içermektedir: "Recommendation: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication". United States Preventive Services Taskforce. 23 Kasım 2020. 5 Mayıs 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mayıs 2022.

uwaterloo.ca

eng.uwaterloo.ca

"Chemical of the Week -- Acetic Acid and Acetic Anhydride". www.eng.uwaterloo.ca. 3 Kasım 2022 tarihinde kaynağından arşivlendi.

web.archive.org

"Aspirin Use During Pregnancy". Drugs.com. 2 Nisan 2018. 12 Ekim 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Aralık 2019.
"OTC medicine monograph: Aspirin tablets for oral use". Therapeutic Goods Administration (TGA). 21 Haziran 2022. 30 Mart 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 4 Nisan 2023.
"Poisons Standard October 2022". Australian Government Federal Register of Legislation. 9 Ocak 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Ocak 2023.
"Zorprin, Bayer Buffered Aspirin (aspirin) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. 7 Nisan 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Nisan 2014.
Brayfield A, (Ed.) (14 Ocak 2014). "Aspirin". Martindale: The Complete Drug Reference. Pharmaceutical Press. 13 Temmuz 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Nisan 2014.
"Aspirin". American Society of Health-System Pharmacists. 29 Kasım 2021. 25 Nisan 2017 tarihinde kaynağından arşivlendi – Drugs.com vasıtasıyla.
Ravina E (2011). The Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs. John Wiley & Sons. s. 24. ISBN 978-3-527-32669-3. 12 Ocak 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.
Jeffreys D (2008). Aspirin the remarkable story of a wonder drug. Bloomsbury Publishing USA. ISBN 978-1-59691-816-0. 8 Eylül 2017 tarihinde kaynağından arşivlendi.
"The Top 300 of 2020". US Government. 1 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022 – ClinCalc vasıtasıyla.
"Aspirin - Drug Usage Statistics, US 2013-2020". ClinCalc. 20 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022.
Dick B (2018). "Hard Work and Happenstance". Distillations. 4 (1). Science History Institute. ss. 44-45. 12 Kasım 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.
"Aspirin". Chemical & Engineering News. 83 (25). 20 Haziran 2005. 21 Nisan 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.
"Acetylsalicylic acid". NIOSH Pocket Guide to Chemical Hazards. U.S. National Institute for Occupational Safety and Health (NIOSH). 11 Nisan 2016. 11 Mayıs 2017 tarihinde kaynağından arşivlendi.
"Appendix G: 1989 Air contaminants update project – Exposure limits NOT in effect". NIOSH pocket guide to chemical hazards. National Institute for Occupational Safety and Health. 13 Şubat 2015. 18 Haziran 2017 tarihinde kaynağından arşivlendi.
"Chemical of the Week -- Acetic Acid and Acetic Anhydride". www.eng.uwaterloo.ca. 3 Kasım 2022 tarihinde kaynağından arşivlendi.
Barrans R (18 Mayıs 2008). "Aspirin aging". Newton BBS. 18 Mayıs 2008 tarihinde kaynağından arşivlendi.
Myers RL (2007). The 100 most important chemical compounds: a reference guide. ABC-CLIO. s. 10. ISBN 978-0-313-33758-1. 10 Haziran 2013 tarihinde kaynağından arşivlendi.
"Acetylsalicylic acid". Jinno Laboratory, School of Materials Science, Toyohashi University of Technology. 4 Mart 1996. 20 Ocak 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 12 Nisan 2014.
"Polytypism - Online Dictionary of Crystallography". reference.iucr.org. 3 Aralık 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.
"The Nobel Prize in Physiology or Medicine 1982". Nobelprize.org. 27 Haziran 2017 tarihinde kaynağından arşivlendi.
"Aspirin in heart attack and stroke prevention". American Heart Association. 31 Mart 2008 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Mayıs 2008.
Goldberg DR (Yaz 2009). "Aspirin: Turn of the Century Miracle Drug". Chemical Heritage. 27 (2). ss. 26-30. 20 Mart 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.
"Bayer Co". cyber.harvard.edu. 29 Ağustos 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Aralık 2023.
"Has aspirin become a generic trademark?". genericides.org. 25 Mart 2020. 5 Mart 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 17 Şubat 2021.
Huth EJ, ve diğerleri. (CBE Style Manual Committee) (1994). Scientific style and format: the CBE manual for authors, editors, and publishers. Cambridge University Press. s. 164. Bibcode:1994ssfc.book.....S. ISBN 978-0-521-47154-1. 15 Ekim 2015 tarihinde kaynağından arşivlendi.
"Aspirin: the versatile drug". CBC News. 28 Mayıs 2009. 6 Kasım 2016 tarihinde kaynağından arşivlendi.
"Aspirin". Sigma Aldrich. 24 Ocak 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Ocak 2022.
"Index BP 2009" (PDF). British Pharmacopoeia. 11 Nisan 2009 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 13 Temmuz 2009.
Bu madde bu kaynaktan gelen kamu malı içermektedir: "Aspirin for reducing your risk of heart attack and stroke: know the facts". U.S. Food and Drug Administration (FDA). 14 Ağustos 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Temmuz 2012.
Bu madde bu kaynaktan gelen kamu malı içermektedir: "Aspirin for the prevention of cardiovascular disease". U.S. Preventive Services Task Force. 11 Temmuz 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Temmuz 2012.
"Medications Used to Treat Fever". American Academy of Pediatrics. 18 Şubat 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Kasım 2012.
"51 FR 8180" (PDF). United States Federal Register. 51 (45). 7 Mart 1986. 19 Ağustos 2011 tarihinde kaynağından (PDF) arşivlendi.
National Clinical Guideline Centre (UK) (July 2013). "Adjunctive pharmacotherapy and associated NICE guidance". Myocardial infarction with ST-segment elevation: the acute management of myocardial infarction with ST-segment elevation [Internet]. NICE Clinical Guidelines. 17.2 Aspirin: Royal College of Physicians (UK). PMID 25340241. 31 Aralık 2015 tarihinde kaynağından arşivlendi.
National Guideline Clearinghouse (NGC). "2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions". United States Agency for Healthcare Research and Quality (AHRQ). 13 Ağustos 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 28 Ağustos 2012.
Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK (August 2001). "Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation" (PDF). The New England Journal of Medicine. 345 (7). ss. 494-502. doi:10.1056/nejmoa010746. PMID 11519503. 6 Ocak 2022 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 10 Aralık 2023.
Bu madde bu kaynaktan gelen kamu malı içermektedir: "Recommendation: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication". United States Preventive Services Taskforce. 23 Kasım 2020. 5 Mayıs 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mayıs 2022.
Aubrey A, Stone W (26 Nisan 2022). "Older adults shouldn't start a routine of daily aspirin, task force says". NPR. 5 Mayıs 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.
National Heart Foundation of Australia (RF/RHD guideline development working group) and the Cardiac Society of Australia and New Zealand (2006). "Diagnosis and management of acute rheumatic fever and rheumatic heart disease in Australia. An evidence-based review" (PDF). National Heart Foundation of Australia. ss. 33-37. 26 Temmuz 2008 tarihinde kaynağından (PDF) arşivlendi.
"Invention of the safety cap". digitaldukemed.mc.duke.edu. 4 Mart 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 4 Eylül 2015.
"Aspirin monograph: dosages, etc". Medscape.com. 13 Temmuz 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Mayıs 2011.
"Aspirin: more evidence that low dose is all that is needed". Medscape. Medscape CME. 27 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Mayıs 2011.
Bu madde bu kaynaktan gelen kamu malı içermektedir: "FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications". U.S. Food and Drug Administration (FDA) (Basın açıklaması). 15 Ekim 2020. 16 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Ekim 2020.
Bu madde bu kaynaktan gelen kamu malı içermektedir: "NSAIDs may cause rare kidney problems in unborn babies". U.S. Food and Drug Administration. 21 Temmuz 2017. 17 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Ekim 2020.
"Aspirin information from Drugs.com". Drugs.com. 9 Mayıs 2008 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Mayıs 2008.
"Oral Aspirin information". First DataBank. 18 Eylül 2000 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Mayıs 2008.
Raithel M, Baenkler HW, Naegel A, Buchwald F, Schultis HW, Backhaus B, ve diğerleri. (September 2005). "Significance of salicylate intolerance in diseases of the lower gastrointestinal tract" (PDF). Journal of Physiology and Pharmacology. 56 (Suppl 5). ss. 89-102. PMID 16247191. 9 Nisan 2011 tarihinde kaynağından arşivlendi (PDF).
"PDR guide to over the counter (OTC) drugs". 10 Nisan 2008 tarihinde kaynağından arşivlendi. Erişim tarihi: 28 Nisan 2008.
"Dengue and dengue hemorrhagic fever: information for health care practitioners". 17 Mart 2008 tarihinde kaynağından arşivlendi. Erişim tarihi: 28 Nisan 2008.
Torborg L (4 Aralık 2018). "Mayo Clinic Q and A: Coated aspirin may not be as effective at reducing blood clot risk". Mayo Clinic News Network. 15 Ocak 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.
"General chemistry online: FAQ: Acids and bases: What is the buffer system in buffered aspirin?". Antoine.frostburg.edu. 14 Nisan 2011 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Mayıs 2011.
"Reye's syndrome". NHS Choices. National Health Service. 12 Ocak 2016. 9 Ağustos 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.
"Are You Sensitive to Aspirin? Here are Some Reasons Why". Health Essentials from Cleveland Clinic. 5 Şubat 2015. 25 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2020.
"FDA strengthens warning of heart attack and stroke risk for non-steroidal anti-inflammatory drugs". U.S. Food and Drug Administration (FDA). 9 Temmuz 2015. 11 Temmuz 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Temmuz 2015.
Kreplick LW (2001). "Salicylate toxicity in emergency medicine". Medscape. 31 Ağustos 2012 tarihinde kaynağından arşivlendi.
Baxter K, Preston CL ((Ed.)). "Aspirin and Spironolactone". MedicinesComplete: Stockley's Drug Interactions. Royal Pharmaceutical Society. 29 Mayıs 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Aralık 2023.
"Aspirin Water Helps Plants". cybercemetery.unt.edu. 2 Nisan 2023 tarihinde kaynağından arşivlendi.
"Gardens: drug therapy for plants | Gardening advice". The Guardian. 29 Mayıs 2022 tarihinde kaynağından arşivlendi.
"Priming Plant Defenses with Aspirin-like Compound : USDA ARS". www.ars.usda.gov. 19 Mayıs 2022 tarihinde kaynağından arşivlendi.
Edwards SH. "Nonsteroidal Anti-inflammatory Drugs: Aspirin". Merck Veterinary Manual. 18 Aralık 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 20 Ocak 2018.
"Analgesics (toxicity)". Merck. 11 Nisan 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Ocak 2018.
"Plants poisonous to livestock". Cornell University Department of Animal Science. 16 Ağustos 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Mart 2016.

worldcat.org

Silva Caldas AP, Chaves LO, Linhares Da Silva L, De Castro Morais D, Gonçalves Alfenas RD (29 Aralık 2017). "Mechanisms involved in the cardioprotective effect of avocado consumption: A systematic review". International Journal of Food Properties. 20 (sup2). ss. 1675-1685. doi:10.1080/10942912.2017.1352601. ISSN 1094-2912. ...there was postprandial reduction on the plasma concentration of IL-6 and IkBα preservation, followed by the lower activation of NFκB, considered the main transcription factor capable of inducing inflammatory response by stimulating the expression of proinflammatory cytokines, chemokines, and adhesion molecules.
Franchi F, Schneider D, Prats J, Fan W, Rollini F, Been L, ve diğerleri. (2021). "TCT-320 Pharmacokinetic and Pharmacodynamic Profile of PL-ASA, a Novel Phospholipid-Aspirin Complex Liquid Formulation, Compared to Enteric-Coated Aspirin at an 81-mg Dose – Results From a Prospective, Randomized, Crossover Study". Journal of the American College of Cardiology. 78 (19). Elsevier BV. s. B131. doi:10.1016/j.jacc.2021.09.1173. ISSN 0735-1097.
Berger JS, Brown DL, Burke GL, Oberman A, Kostis JB, Langer RD, ve diğerleri. (March 2009). "Aspirin Use, Dose, and Clinical Outcomes in Postmenopausal Women With Stable Cardiovascular Disease". Circulation: Cardiovascular Quality and Outcomes. 2 (2). ss. 78-87. doi:10.1161/circoutcomes.108.791269. ISSN 1941-7713. PMC 2801891 $2. PMID 20031819.
Sacristán JA (August 2021). "Aspirin Dosing in Cardiovascular Disease". New England Journal of Medicine. 385 (8). ss. 764-765. doi:10.1056/nejmc2110476. ISSN 0028-4793. PMID 34407352.
"Randomised Trial of Intravenous Streptokinase, Oral Aspirin, Both, or Neither Among 17,187 Cases of Suspected Acute Myocardial Infarction: Isis-2". The Lancet. 332 (8607). August 1988. ss. 349-360. doi:10.1016/s0140-6736(88)92833-4. ISSN 0140-6736. PMID 2899772.
Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, ve diğerleri. (August 1983). "Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study". New England Journal of Medicine. 309 (7). ss. 396-403. doi:10.1056/NEJM198308183090703. ISSN 0028-4793. PMID 6135989.
Di Bella S, Luzzati R, Principe L, Zerbato V, Meroni E, Giuffrè M, ve diğerleri. (25 Ocak 2022). "Aspirin and Infection: A Narrative Review". Biomedicines. 10 (2). s. 263. doi:10.3390/biomedicines10020263. ISSN 2227-9059. PMC 8868581 $2. PMID 35203473.